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Trifolirhizin is a potent polycyclic flavonoid with anticarcinogenic effects. 
The treatment of 25 μM trifolirhizin in human derived prostate cancer LNCaP cells 
for 6 days decreased cell proliferation by 40%. Higher dosages caused the 
proliferation inhibition effect to be manifested in as early as 3 days. Another prostate 
cancer cell line, PC-3, was not affected by trifolirhizin till 125 μM resulting in about 
45 % reduction in cell proliferation after 4 to 6 days of incubation. Most importantly, 
for normal human prostate epithelial (NHPrE) cells, trifolirhizin was effective only at 
the highest concentration of 200 µM. The proliferation inhibition in trifolirhizin-
treated LNCaP and PC-3 cells was associated with cell cycle arrest at the G0/G1 and 
G2/M phase, respectively. Moreover, the expression of cyclin E was unchanged but 
that of cyclin D1, p53, p21 and p-Rb was suppressed in 50 μM trifolirhizin-treated 
LNCaP cells.  
To evaluate the influence of resveratrol on cellular zinc status, NHPrE cells 
were treated with 6 levels of resveratrol (0, 0.5, 1, 2.5, 5 and 10 μM) and 4 levels of 
  
zinc [0, 4, 16 and 32 μM representing zinc deficient (ZD), zinc normal (ZN), zinc 
adequate (ZA) and zinc supplemented (ZS), respectively]. Among each zinc treatment, 
a progressive reduction in cell growth or increase in cellular total zinc was observed 
with increases of resveratrol from 2.5, 5 and 10 μM or from 5 and 10 μM, 
respectively. In ZS cells a much higher increase in cellular total zinc was observed as 
early as 1 μM resveratrol. The resveratrol (10 μM) induced G2/M arrest was found to 
be responsible for the depressed cell proliferation. An in vitro experiment 
demonstrated complex formation between resveratrol and zinc ion. Fluorescent 
spectrofluorimetry and microscope imaging revealed that intracellular free labile zinc 
decreased in resveratrol-treated ZD and ZN NHPrE cells but increased in high zinc 
(ZA and ZS) cells. Furthermore, increases in cellular zinc status induced reactive 
oxygen species (ROS) generation as well as senescence in cells treated with 2.5 or 10 
μM resveratrol, especially in ZA and ZS cells. Thus, increase in free labile zinc may 
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CHAPTER I: INTRODUCTION 
1.1 General Introduction 
Nature produces a large pool of organic natural products including polyketides, 
terpenoids, amino acids, proteins, carbohydrates, lipids, nucleic acid bases, RNA and 
DNA. These materials, which are derived from a variety of living creatures such as 
plants, animals, marine organisms and microorganisms (Mukherjee et al., 2001), 
reflect directly on the impact of evolution on the self-defense system employed by 
living creatures to repel or destroy their predators or archenemies and represent an 
enormous resource for medical treatments. Since most plants have limited mobility, 
the chemical diversity has helped them develop sophisticated defensive mechanisms 
including delicate chemical arsenal of toxic substances, such as terpenes and alkaloids, 
that exert growth inhibition effect on other plants and keep predators away (da Rocha 
et al., 2001). Plant based natural products have been used for traditional medicine 
worldwide ever since ancient eras. Even today, although a large portion of drugs are 
synthesized or processed by medicinal chemistry, drugs derived from plant based 
natural products continue to contribute significantly to modern medication.  
This dissertation includes results from two projects concerning two 
phytochemicals originated from plants with potential beneficial effect for human 
health, trifolirhizin and resveratrol, will be presented. The trifolirhizin project was 
mainly focused on elucidating the anticancer mechanism of this phytochemical. The 




and apoptosis induction on human prostate cancer cell lines as well as on normal 
prostate cells in primary cultures was examined. Data generated from this project will 
contribute to the understanding of the molecular mechanism(s) of trifolirhzin. 
Specifically the results may aid in the discovery of new effective compounds as 
potential anticancer chemopreventive and chemotherapeutic agents of plant origin. 
The resveratrol project was initiated in response to a large volume of reports 
on the health-promoting effect but lack of data on undesired aspects of resveratrol, 
specifically, the prooxidant activity coming from its interaction with divalent metal 
ion, e.g. Cu. The NHPrE cells were selected as our model system because they 
represent normal prostate tissue and accumulate high levels of zinc. Data generated 
will not only contribute to the development of biomarkers for the measurement of 
health outcomes of the bioactive resveratrol, together with its interactions with the 
essential trace metal, zinc, but also aid in providing updated information for the 
setting of dietary reference intakes for resveratrol and zinc, as well as in the design of 
clinical studies for further exploration of the interaction between resveratrol and zinc 
in human subjects.  
1.2 References  
da Rocha, A. B., R. M. Lopes, & G. Schwartsmann. (2001). Natural products in 
anticancer therapy. Curr Opin Pharmacol 1:364-369. 
Mukherjee, A. K., S. Basu, N. Sarkar, & A. C. Ghosh. (2001). Advances in cancer 






CHAPTER II: LITERATURE REVIEW 
2.1 Prostate and Prostate Cancer 
The prostate is a sexual organ comprised of branched glands, with ducts lined 
by secretory epithelial cells and basal cells (McNeal, 1988). The major function of 
prostate in human body is to produce seminal fluid to facilitate sperm motility. There 
are four major zones within the normal prostate: the peripheral zone, which 
constitutes about 70% of glandular tissue, the central zone (20%), the transition zone 
(5%) and the anterior fibromuscular stroma (5%) (McNeal, 1981). Prostate carcinoma 
most commonly develops in the peripheral zone (McNeal et al., 1988). 
In the United States, prostate cancer is the second leading cause of cancer-
related deaths in men (Jemal et al., 2006). More than 10% of men over the age of 65 
are diagnosed with prostate cancer (Bosland et al., 2002; Jemal et al., 2006). 
Morbidities are mainly caused by the cancer cell progression from androgen-
dependent state to androgen-independent state, which fails to respond to hormone 
ablation therapy (Dong, 2006; Kopper and Timar, 2005; Tang and Porter, 1997; 
Denmeade et al., 1996). Several key regulatory genes in the cellular program that 
determine cell proliferation, programmed cell death and cellular processes against 
environmental agents including GSTP1, PTEN, p53 and androgen receptor (AR) have 
been found to be associated with prostate cancer development (Dong, 2006; Kopper 
and Timar, 2005; Simard et al., 2003). As there are only few options in surgery and 
chemotherapy, identification and development of alternative chemopreventive and 




2.2 Cell Cycle Progression, Apoptosis and Cancer 
Deregulation of cell cycle and destruction of normal cellular proliferation can 
lead to uncontrolled cell proliferation and eventually cancer. Cellular cell cycle or cell 
division cycle is referred to as a series of events in eukaryotic cells taking place 
between one division and the next. Generally, human cell cycle consists of four 
phases including G1, S, G2, and M. When there is cell proliferation, cell enters G1 
phase during which new nucleosides and proteins are synthesized for the preparation 
of DNA synthesis that usually occurs in the S phase, a phase following G1. A cell at 
G1 phase can either proceed to S phase smoothly with a green signal from a 
molecular surveillance system at the checkpoint between G1 and S or enter a state of 
quiescence, G0 phase, where cell division has temporarily or semi-permanently 
stopped and the cell carries out its ordinary role for the organism. The next phase, G2 
phase, follows successful completion of DNA synthesis and chromosomal replication, 
and then mainly focuses on preparing other structures imperative for mitosis, the M 
phase, where two daughter cells are produced. Between the G2 and M phase, the 
G2/M checkpoint which monitors cellular fitness of proceeding to enter mitosis, 
prevents cells with damaged DNA from carrying out mitosis, and provides an 
opportunity for DNA repair and puts a stop to the proliferation of genetically 
damaged cells (Morgan, 2007; Lodish et al., 2004).  
Apoptosis, also known as programmed cell death, plays a vital role in the 
regulation of cellular activities in eukaryotes and is highly conserved in evolution 
(Wyllie et al., 1980). Basically, cells undergoing apoptosis exhibit phenomena 




membrane integrity and generation of apoptotic bodies (Van and Van Den, 2002). 
There are two major apoptotic pathways: the extrinsic pathway that favors the 
activation of the TNA/Fas death receptor family and involves caspases 8 as a 
downstream signal mediator and the intrinsic pathway involving the mitochondria and 
caspases 9. The caspase proteins, the major executioners of this process, are generally 
considered imperative in either pathway of apoptosis (Nicholson, 1999). Disturbance 
of apoptosis, especially the interruption of the expression of genes involved in 
apoptosis regulation, is highly related to cancer occurrence.  
Cancer begins to initiate when normal cells, supposed to differentiate into 
various specialized subsets required for specific tissue function or chemical 
production after a period of proliferation, are mutated or damaged genetically. These 
cells escape from the systematic surveillance, survive the programmed cell death and 
proliferate inappropriately without any control. Since many cancer cell lines are 
resistant to cell death, apoptosis induction has recently become a popular idea in 
cancer treatment. Many anticancer drugs used clinically in chemotherapy nowadays 
have been demonstrated to share a common anticancer mechanism of cell cycle 
inhibition or apoptosis induction.  
2.3 Zinc 
Zinc is an integral component of a wide variety of functional proteins such as 
enzymes and transcription factors, where it exerts specific actions over a wide range 
of physiological processes such as growth, development, and functioning of the 
endocrine, immune, and nervous systems (Prasad, 1983; Vallee and Falchuk, 1993; 




Epidemiological studies have reported dietary zinc deficiency as a factor strongly 
associated with an increased incidence of esophageal carcinoma in men (Barch, 1989). 
Concentrations of tissue copper and zinc, as well as copper/zinc ratio are increased in 
human pancreatic cancer from 1.40 to 2.70 (Ebadi and Swanson, 1988). In addition, 
serum zinc levels were shown to be low and urinary zinc excretion to be high in 
patients with significantly reduced and increased, respectively, in patients with 
bronchial carcinoma as abnormal zinc metabolism. Interestingly, the inductions of 
certain types of cancer including esophagus, liver, kidney, and small intestine cancer 
by known carcinogens have been found to be enhanced by zinc deficiency (Fong et 
al., 1978). Moreover, reductions of zinc status may promote apoptosis in certain cell 
types (Franker and Telford, 1997) and depress G1/S cell type progression in HepG2 
cells (Cui et al., 2002). In contrast, supplementation of zinc has been shown to 
depressed G2/M progression in normal human bronchial epoithelial cells (Shih et al., 
2006). Similarly, G2/M arrest has been observed in zinc supplemented human 
prostate carcinoma cell lines, LNCaP (p53+/+) and PC-3 (p53-/-) cells, indicating that 
the impared cell cycle progression may be independent of p53, since the existence of 
p53 gene in these cell lines does not affect the manifestation of the cell cycle arrest 
effect (Liang et al., 1999). Thus zinc deficiency and supplementation may depress 
normal cell cycle progression and functions. 
2.3.1 Functions of zinc in normal prostate 
Prostate has been known to contain remarkably high zinc content since as 
early as the 1920s by Bertrand and Vladesco (1921). It was reported that normal 




as liver and kidney; and the glandular epithelial cells in the peripheral zone of 
prostate accumulate the highest levels of total intracellular zinc (Suzuki et al., 1991; 
Costello et al., 2004). Low zinc content in seminal plasma may cause infertility in 
men by mitigating the mobility of sperm (Koca et al., 2003; Pant 2003; Pant and 
Srivastava, 2003). The major essential functions of prostate secretary epithelial cells 
are accumulation of cellular zinc and secretion of zinc into the prostatic fluid by the 
prostate glands (Sorensen et al., 1997). The zinc-accumulating function of secretary 
epithelial cells has been connected to the inhibitory effect of high cellular zinc on net 
citrate production via Kreb cycle (Costello et al., 1997). In these cells, zinc was 
shown to inhibit the mitochondrial aconitase activity and prevent the oxidation of 
citrate accumulated in mitochodria and secreted into prostatic fluid, while in other 
mammalian cells, the inhibition of m-aconitase activity and citrate oxidation is lethal.  
There are reports indicating that intracellular zinc levels in malignant prostate 
epithelial cells are 70%-80% lower than the surrounding normal epithelial cells 
(Zaichick et al., 1997; Feustel and Wennrich, 1984). Moreover, a strong, inverse 
correlation between plasma zinc levels and various prostatic diseases was reported, 
with 83% rise in benign prostatic hyperplasia (BPH) and 37% fall in patients with 
malignancy as compared to normal patients (Goel and Sankhwar, 2006). In 
accordance with plasma level, the whole blood zinc levels in prostate cancer patients 
were 25% lower than the controls (Picurelli et al., 1991; Ozmen et al., 2006).  
2.4 Phytochemicals 
‘Phytochemicals’ is a term refering to as a group of bioactive, plant-derived, 




Phytochemicals, characterized as a highly sustainable, easily obtainable and large-
scale plantable resource, became potent candidates for drug development targeting 
the treatment and prevention of prostate cancer. They appeared to be promising 
because of their chemopreventive and chemotherapeutic actions reported in 
epidemiologic and experimental studies (Hong and Sporn, 1997; Kucuk, 2002; 
Barnes, 2001). 
2.4.1 Proposed anticancer mechanisms of dietary phytochemicals 
Research on the anticancer activity of numerous phytochemicals has 
demonstrated that phytochemicals in common fruits, vegetable as well as medicinal 
plants possess complementary and overlapping mechanisms of action (Table 1). 
These mechanisms that have been reported include antioxidant activity and free 
radical scavenging; inhibition of cell proliferation, oncogene expression and signal 
transduction pathways; regulation of gene expression in cell differentiation and 
proliferation; induction of oncogene expression, cell cycle arrest and apoptosis; 
modulation of enzyme activities in detoxification, oxidation, and reduction; 
stimulation of the immune system; regulation of hormone metabolism; as well as 




Table 1: Proposed mechanisms by which dietary phytochemicals may prevent 
cancer 
Antioxidant activity 
  Scavenge free radicals and reduce oxidative stress 
Inhibition of cell proliferation 
Induction of cell differentiation 
Inhibition of oncogene expression 
Induction of tumor suppress gene expression 
Induction of cell-cycle arrest 
Induction of apoptosis 
Inhibition of signal transduction pathways 
Enzyme induction and enhancing detoxification  
  Phase II enzyme 
  Glutathione peroxidase 
  Catalase 
  Superoxide dismutase 
Enzyme inhibition 
  Phase I enzyme (block activation of carcinogens) 
  Cyclooxygenase-2 
  Inducible nitric oxide synthase 
Xanthine oxide 
Enhancement of immune functions and surveillance 
Antiangiogenesis 
Inhibition of cell adhesion and invasion 
Inhibition of nitrosation and nitration 
Prevention of DNA binding 
Regulation of steroid hormone metabolism 
Regulation of estrogen metabolism 
Antibacterial and antiviral effects 




2.4.2 Anticancer roles of Asian phytochemicals (In vitro evidence) 
In this section, plant natural products have been shown to exert their 
anticancer functions by antiproliferation, induction of apoptosis, inhibition of DNA 
synthesis and DNA damage. Although many phytochemicals exert their anticancer 
activities through multiple mechanisms, antiproliferation and induction of apoptosis 
appear to be a common mechanism. Nearly every effective component listed in the 
table 2 and 3 is cytotoxic to cancer cells in a dosage and time dependent manner to 
different extent in their own experimental system. Exceptions include a 60kd protein 
isolated from the Acanthopanax gracilistylus extract, which can only inhibit the 
proliferation of cancer cells such as MT-2, Raji, HL-60, TMK-1 and HSC-2 but not 
induce cell death at the highest concentration of 10μg/ml (Shan et al., 2000). In 
addition, several bioactive anthraquinones, of which anti-tumor activity is not 
mediated by cytotoxic mechanism, as exemplified by the fact that more than 75% of 
the CNS and colon cancer cells remained viable after 48h of treatment with the 
anthraquinones at their GI50 concentrations (Cichewicz et al., 2004. The broad-
spectrum antiproliferative activity of these bioactive compounds is indicative of their 
potential as chemopreventive drug candidates.  
Favored apoptosis pathway: intrinsic pathway 
With all the available information about the molecular events listed in table 2 
and 3, it is not difficult to find out that most of the phytochemicals included favor the 
intrinsic apoptosis pathway, which involves the mitochondria and caspase 9. In the 
intrinsic apoptosis model, a group of proto-oncogene, tumor suppressor genes and 




proteins, transfers signals leading to a change in mitochondria membrane 
permeability and the release of cytochrome c during the initial phase of apoptosis. 
Members of the Bcl-2 family either promote cell survival (e.g., Bcl-2 and Bcl-XL) or 
induce apoptosis (e.g. Bax) (Gross, 2001; Crompton, 2000). The ratio of Bax/Bcl-2 is 
critical for the induction of apoptosis and determines whether cells will undergo 
apoptosis (Reed, 1995). An increase in the Bax/Bcl-2 ratio indicates cells are 
stimulated to release cytochrome c from mitochondria into the cytosol, where an 
apoptosis complex ‘apopsome’ is formed by cytochrome c and Apaf-1 and then 
activates the caspase 9 and other execution caspases of the cascade, which turn on the 
irreversible apoptotic signaling pathway (Hoffman and Liebermann, 1994). However, 
not all the intrinsic apoptosis pathways induced by these compounds are through 
caspase activation. There is evidence indicating that the apoptosis induction by 
magnolol treatment in U937 Cells is caspase-independent and mediated by the release 
of AIF from mitochondria (Ikai et al., 2006). Another case of caspase-independent 
apoptosis was reported in trofolirhizin and maackiain treated HL-60 cells and the 
apoptosis was mediated by generation of active oxidants by these two compounds 
(Aratanechemuge et al., 2004). Whether the apoptosis was intrinsic or extrinsic still 
requires further experimentation. The extrinsic apoptotic pathway was also reported 
in a very low frequency. In one case, shikonin from Lithospermum erythrorhizon 
induced apoptosis in HeLa cells by activation of caspase-8, not caspase-9, which 
triggers the mitochondrial pathway-independent caspase cascades, leading to 
activation of caspase-3 and DNA fragmentation simultaneously (Wu et al., 2004). 




cells by tetrandrine from Stephania tetrandra involved both caspases-8 and -9 
activation. The findings of caspase -8 activation preceded by that of caspase-9, the 
release of cytochrome c, cleavage of Bid and downregulation of Bcl-XL, however, 
suggested that the mitochondrial pathway was primarily involved in the tetrandrine-
induced apoptosis (Oh and Lee, 2003). 
Cell cycle arrest dependency on compounds and cell types  
Interestingly, berberine can not only induce G0/G1 cell cycle arrest in human 
prostate cancer DU145 cells (Mantena et al., 2006), but also induce G2/M cell cycle 
arrest in human gastric carcinoma SNU-5 cells (Lin et al., 2006). More intriguingly, 
berberine treatment at the comparable dosage induced apoptosis with G0/G1 and 
G2/M cell cycle arrests in murine leukemia L1210 cells (Jantova et al., 2003) but 
exerted no cell cycle arrest effect in Ehrlich ascites carcinoma cells (Letasiova et al., 
2006). These findings suggested that the berberine induction of cell cycle arrest may 
be dependent on cell types. Another compound, shikonin, induced G1/S blockage in 
A375-S2 cells through the activation of caspase 9 and a typical intrinsic apoptotic 
pathway (Wu et al., 2004). However, in HeLa cells, shikonin acted through the 
activation of caspase 8, a hallmark of extrinsic apoptotic pathway (Wu et al., 2004). 
The shikonin treatment can also induce apoptosis without cell cycle arrest in COLO 
205 cells while exhibiting similar molecular events favoring the intrinsic apoptotic 
pathway (Hsu et al., 2004). Therefore, the anticancer effects of these compounds may 
be exerted through different mechanisms in different cell types. Even if the same 
natural product causes the same cell cycle arrest, the mechanism may not be the same 




arrested the COLO-205 cells at the G0/G1 phase of the cell cycle (Lin et al., 2002). In 
contrast, it was not reported to influence the cell cycle in CH27 cells (Yang et al., 
2003). One common finding for both studies was that magnolol was able to induce 
apoptosis in these two kinds of cells. Careful examination of these two papers reveals 
that it is possible that cell cycle arrest also exits in CH27 cells treated with magnolol 
but the flow cytometric periment was not carried out because these investigators 
focused their interests mainly on the molecular pathway of apoptosis.  
From the aspect of cell types, prostate cancer cells including both androgen-
unresponsive (DU-145 and PC-3) as well as androgen-responsive (LNCaP) types tend 
to be arrested at G1 phase when treated with ducursin (Yim et al., 2005), berberine 
(Mantena et al., 2006) and ginsenoside Rg3 (Liu et al., 2000). In contrast, the cell 
cycle arrest effects on the tsFT210 and K562 cells are more drug-dependent, showing 
a G0/G1 arrest with the treatment of labdane-type diterpenes (Li et al., 2005) and a 
G2/M arrest with the treatment of flavonoids (Li et al., 2005), although both types of 
compound are isolated from the same medicinal plant, Vitex trifolia. 
With normal cells as control 
The majority of the experimental studies that we have discussed above were 
concentrated on the anticancer effects of these bioactive compounds on cancer cells, 
while lacking the cytotoxic effects on normal cells. Only a very small portion of 
studies have included normal cells in their experimental system to address this 
cytotoxic effect issue (Table 3). In 1999, Lee et al. reported that water or organic 
solvent extract fractions from Selaginella tamariscina exhibited significant 




human lymphocytes (Lee et al., 1999). Recently, in a prostate cancer model, three 
cancer cell lines including DU145, PC-3 and LNCaP and nonneoplastic human 
prostate epithelial PWR-1E cells were tested against a novel anticancer agent, 
decursin from Angelica gigas, for its anticancer effects. For the first time, decursin 
(25-100 μM) treatment for 24 to 96 hours was found to strongly inhibit growth by 
causing a strong G1 arrest, and induce cell death in these three carcinoma cell lines. 
Comparatively, decursin was nontoxic to PWR-1E cells and only moderately 
inhibited their growth and showed slight G1 arrest. Further molecular examination 
revealed that there were no significant changes of the level of proteins between drug-
treated and non-treated PWR-1E cells (Yim et al., 2005). Berberine from Berberis 
poiretii and Mahonia bealei was applied to the same cell model system and similar 
results were observed. The treatment of PWR-1E with berberine, under identical 
conditions, significantly inhibited proliferation and induced cell death associated with 
G1-phase cell cycle arrest in DU145, PC-1 and LNCaP cell lines, but did not affect 
the viability and cell cycle progression of PWR-1E cells (Mantena et al., 2006). In 
another study, magnolol, a hydroxylated biphenyl compound isolated from Magnolia 
officinalis, at very low concentrations (3-10 μM) inhibited DNA synthesis and cell 
growth in cultured human COLO-205 and HepG2 hepatoblastoma cells in a dose-
dependent manner, but not in human untransformed cells such as keratinocytes, 
fibroblasts, and human umbilical vein endothelial cells (HUVEC). However, 
magnolol did not show any effect on cell death or cell cycle arrest in both cancer cells 
and normal cells, probably due to these low concentrations (Lin et al., 2002). The 




Subprostrate, significantly induced apoptosis in leukemia HL-60 cells, whereas no 
induction of apoptosis was observed in normal lymphocytes treated with the same 
concentration. In sum, the tested compounds or extracts are selectively effective for 
cancer cells but not for normal cells. They exerted nontoxic and/or moderate growth 
inhibition effects on normal cells while significantly inhibited the growth and induced 















2.4.3 Anticancer roles of Asian phytochemicals (In vivo evidence) 
Experiments in animals, especially in mice, were conducted to explore the 
anticancer effects of interested plant natural products (Table 4). Several compounds, 
including decursinol angelate and decursin from Angelica gigas (Lee et al., 2003), 
cordycepin from Cordyceps sinensis (Yoshikawa et al., 2004), euscaphic acid from 
Eriobotrya japonica (Banno et al., 2005), glycosides from Prunus persica (Fukuda et 
al., 2003), magnolol from Magnolia officinalis (Lin et al., 2002) and [6]-gingerol 
from Zingiber officinale (Park et al., 1998; Katiyar et al., 1996) have been explored 
for their in vivo anti-tumor activities. These compounds tested for potential 
biopotency seem to share the same mechanism by inhibiting skin tumor initiation and 
growth in the mice system. Treatment with these bioactive compounds can 
significantly reduce the average number of tumor bearing mice, as well as incidence 
of tumor formation in mouse skin when compared with the control treated only with 
tumor initiator and promoter. As far as the molecular basis was concerned, p21 level 
of the tumor cells implanted subcutaneously into nude mice was found elevated by 
the treatment of magnolol (Lin et al., 2002). This finding suggests the inhibition of 
the progression of cell cycle activity was involved in the magnolol induced tumor 
regression, which coincided with the in vitro experimental results. Therefore, the 
validity of the results of in vitro system in this study was supported by similar data 
from in vivo system.  




Park et al, 1998 and Katiyar et al. 1996 reported that the ethanol extract and 
pure compound [6]-gingerol exert their anticancer effect on mice skin papilloma by 
inhibition of TPA induction of epidermal ornithine decarboxylase (ODC) activity. 
ODC is a rate-limiting enzyme in the biosynthesis of polyamines, a prerequisite for 
cell proliferation, differentiation, and neoplastic transformation. The induction of 
ODC has been suggested to be highly correlated with tumor promotion; while the 
inhibition of ODC has shown promising results for screening inhibitors of 
tumorigenesis. However, these two studies could not establish whether the 
compounds inhibited the action of the tumor promoter and/or the enzymatic 
pathway(s). Several years later, the same group of scientists found that [6]-gingerol 
reduces COX-2 expression by blocking the activation of p38 MAP kinase and NFκB 
in TPA-stimulated mouse skin, demonstrating modulation of abnormal upregulation 
of these intracellular signaling molecules could be the mechanism of 
chemopreventive activity exerted by some phytochemicals (Kim et al., 2005). 
Interestingly, in another study, [6]-gingerol was shown to inhibit the sprouting of 
endothelial cells in the rat aorta ex vivo and formation of new blood vessel in the 
mouse cornea in response to VEGF, as well as reduce the number of lung metastasis 
in mice receiving i.v. injection of B16F10 melanoma cells, suggesting strong anti-
angiogenic activity may be employed in the treatment of tumors and other 
angiogenesis-dependent diseases (Kim et al., 2005). The evidence cited above along 
with the ones in the in vitro experiments about [6]-gingerol suggest that one 














2.4.4 A proposed molecular model for Asian phytochemicals 
Despite the diversity of compounds, extracts and medicinal plants discussed 
above, a scrutinized examination of the molecular events involved in the anticancer 
actions exerted by these materials reveals a common pattern (Figure 1) that accounts 
for the similarity exhibited in the functionary mechanisms. Although there might be 
slight divergence or incompleteness in some cases, in general, treatment of various 
cancer cells with these natural plant products markedly elevated the p53 expression. 
On one hand, the increase in p53 caused decrease of cyclins and CDKs, increase of 
expression of CDK inhibitor p21 and p27 as well as enhanced CDK/CDK inhibitor 
interaction, resulting in cell cycle arrest. On the other hand, the elevated p53 
decreased mitochondrial membrane potential; and promoted cytochrome c release by 
generating reactive oxygen species (ROS) and elevating the Bax/Bcl-2 ratio; as well 
as further activated caspase 9 and downstream caspase cascade leading to intrinsic 
apoptosis. Cautions must be applied about the pivot role of p53 in this model. There 
has been evidence indicating that p21 can function as a tumor suppressor in a p53 
independent manner (Chen et al., 2004), suggesting p53 may not be the only regulator 
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Figure 1. Proposed anticancer mechanism of Asian plant natural products. 






Trifolirhzin is a naturally occurring polycyclic flavonoid in Sophorae Radix, 
derived from the roots of Sophora flavescens, a traditional Asian medicinal plant that 
has been used as a diuretic, stomachic, antipyretic, and anthelmintic for centuries 
(Zhao and Xiao, 2006). Although alkaloids and flavonoids from Sophora flavescens 
have exhibited a wide spectrum of antitumoral effects (Zhang et al., 2001; Sun et al., 
2007; Han et al., 2007), the research on the application of trifolirhizin on cancer 
prevention and treatment was not well documented.  
2.5.1 Anticancer activity of trifolirhizin 
Trifolirhizin has been shown to inhibit cell proliferation of several tumor cell 
lines, which include A549 (non small cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), 
XF498 (central nerve system) and HCT-15 (colon) with the ED50 from 33.6-84.8 µM 
(Ryu et al., 1997). In human promyelotic HL-60 leukemia cells, trifolirhizin exerts its 
anticancer activity by growth inhibition and apoptosis induction mediated by change 
in oxidation stress in a concentration and time dependent manner (Aratanechemuge et 
al., 2004). A recent article reported trifolirhizin also possess tyrosinase inhibitory 
activity and can markedly inhibit (>50%) tyrosinase-dependent melanin biosynthesis 
at 50 µM in cultured B16 melanoma cells (Hyun et al., 2008). However, most of these 
reports did not contrast the effects of trifolirhizin on cancer cell lines and on their 





Resveratrol (3, 4’, 5-trihydroxystilbene) is a phytoalexin synthesized in the 
fruits of a wide variety of plants (which include grapes, peanuts and mulberries) in 
response to environmental stress, injury, UV irradiation, and fungal infection 
(Hammerschmidt, 1999). The pioneering work of Hain et al. 1993 demonstrated that 
resistance to Botrytis cinerea infection was found to be enhanced in transgenic 
tobacco plant with the addition of stilbene synthase genes from grapevine. 
Resveratrol is also the active compound found in the roots of Polygonum species for 
the preparation of “kojokon”, a traditional Asian medicine for the treatment of several 
diseases, in particular, lipid disorders (Kimura et al., 1983; Kimura et al., 1985). In 
the grapevine, resveratrol is synthesized as a trans-isomer mainly at the skin of grape 
berries and is found at much higher levels in red than white wines (Jeandet et al., 
1991; Jeandet et al., 1993). Red wine contains 1 to 10 mg of resveratrol per L (4 to 40 
µM) (Goldberg et al., 1996). In the US and Europe, resveratrol is commercially 
available as a nutraceutical, ranging from 50 µg to 100 mg per dosage. Oral intakes of 
resveratrol at 50 mg/kg body weight in rats can attain plasma resveratrol 
concentration of as high as 10 µM (Marier et al., 2002). A recent human study 
reported single dose intakes of up to 5 gram of resveratrol resulted in peak plasma 
level of 2.4 µM at 1.5 h post-dose (Boocock et al., 2007). Moreover, peak levels of 
two monoglucuronides and resveratrol-3-sulfate were 3- and 8-fold higher, 
respectively. These levels are close to the systemic concentration of about 5 µM, 
suggested by mechanistic in vitro cellular studies, to be required to elicit bio-activities 




Delmas et al., 2002; Jang et al., 1997; Sale et al., 2005; Soleas et al., 2001). However, 
concentrations needed to elicit bioactivities in studies in vitro may only be a rough 
estimate of levels required for efficacy in vivo. Thus, future human studies are needed 
to establish if repeated or continuous dosing schedules may attain higher systemic 
concentrations of resveratrol and if the glucocuronide and sulfate metabolites, which 
are abundantly synthesized after resveratrol consumption, may possess bioactivities 
by themselves. 
The interest in resveratrol was initiated by the “French paradox”, the relatively 
low prevalence of coronary heart disease in Southern France, despite high dietary 
saturated fat intake (Renaud and de, 1993). This finding is correlated with the 
region’s moderate intake of red wine that contains resveratrol, which has been 
identified as the major component responsible for the health benefits. Relevant to its 
widely considered cardiovascular protective properties, resveratrol has been shown to 
exert a number of anti-inflammatory (Jang et al., 1997), antiangiogenic (Cao et al., 
2005; Tseng et al., 2004) and anti-mutagenic (Uenobe et al., 1997) effects, as well as 
to function as an estrogen receptor agonist (Gehm et al., 1997). Similar to other 
polyphenolic compounds, resveratrol is redox active and has been identified as an 
antioxidant (Li et al., 2006; Orallo, 2006) capable of quenching highly reactive free 
radicals via their donation of a hydrogen atom to form less reactive phenoxyl radicals 
(Mitchell et al., 1998). This interception of free radicals by resveratrol and phenolic 
compounds suppresses destructive self-propagating chain reactions, such as lipid 
peroxidation, thereby sparing α-tocopherol.  In addition, phenolic compounds may 




and copper (Iwahashi et al., 1990; Brown et al., 1998). In deed, the inhibition of LDL 
oxidation by resveratrol (Frankel et al., 1993) was attributed to its ability to chelate 
Cu ions as well as by free radical scavenging mechanism (Belguendouz et al., 1997). 
Resveratrol was established as the most potent chelator of Cu but not of iron (Fe).  
Studies of cells in culture and isolated subcellular models in vitro implicate a 
number of mechanisms for the pharmacologic function of resveratrol (Gescher & 
Steward, 2003). These mechanisms involve the induction of p53 (Soleas et al., 2001), 
cyclin A, cyclin B1, CDK1 and 2 (Delmas et al., 2002), and Fas/Fas ligand-mediated 
apoptosis (Clement et al., 1998). In addition, resveratrol has been demonstrated to 
suppress the expression and activity of cyclooxygenase enzymes (Sale et al., 2005), 
androgen actions (Bhat et al., 2001), activation of SIRT1 (Howitz et al., 2003), NF-
κB (Banerjee et al., 2002), and cytochrome P-450 isoenzyme 1A1 (Ciolino and Yeh, 
1999). Moreover, resveratrol has been implicated to delay the development of colonic 
aberrant crypt foci (Tessitore et al., 2000), esophageal (Li et al., 2006) and mammary 
malignancies (Bhat et al., 2001) as well as inhibit solid hepatoma growth and 
metastasis in rats (Miura et al., 2003). Furthermore, in the LNCaP prostate cancer 
cells, limited available data suggested that resveratrol inhibits growth (Hsieh and Wu, 
1999), cell cycle progression into the S phase, and DNA synthesis (Kuwajerwala et 
al., 2002), as well as increases apoptosis (Lin et al., 2002). The inhibitory effect of 
resveratrol on cell growth may be due to the associated increases in p53 expression 
and serine phosphorylation of p53 (Narayanan et al., 2003). Thus, the activation of 
p53 dependent pathway may contribute to the growth inhibitory effect of resveratrol. 




antigen (PSA) (Hsieh and Wu, 1999). However, the molecular mechanisms exerted 
by resveratrol on these changes remain unclear. Nevertheless, in-vitro data generally 
support a beneficial effect for resveratrol on prostate cancer. Currently, very limited 
data are available on the influence of resveratrol on normal human prostate cells or 
other normal human cell types, which make this proposed project highly relevant and 
timely.   
 
2.6.1 Interactions between resveratrol and Cu 
Many studies have reported potential harmful pro-oxidant properties of 
polyphenolic compounds at high concentrations because of their ease of oxidation in 
the presence of metal ions. The DNA cleaving prooxidant activity of resveratrol in the 
presence of Cu ions was first reported by Fukuhara and Miyata, 1998. Thereafter, the 
mechanism of DNA cleaving prooxident activity of resveratrol was found to involve 
the formation of resveratrol-Cu(II) complex resulting in the reduction of Cu ions and 
the formation of ROS (Ahmad et al., 2000). This prooxidant activity of resveratrol 
was acompanied by its ability to inactivate bacteriophage λ by the DNA cleavage 
mechanism. Resveratrol has been shown to cause oxidative single strand breakage in 
DNA either alone or in the presence of transition metal ion like copper. In the 
chromatin, copper the most redoxactive metal ion is associated with DNA bases, 
particularly guanine (Kagawa et al., 1991). Resveratrol and other polyphenols have 
been shown to induce apoptotic cell death in various cancer cell lines but not for 
normal cells (Clement et al., 1998). The cytotoxic effect has been proposed to involve 




presence of Cu (II) has been confirmed to cause DNA degradation in peripheral 
lymphocytes derived from human blood. Moreover, the inhibition of DNA 
degradation in lymphocytes by scavengers of reactive oxygen and by neocuproine, a 
Cu(I) specific sequester, demonstrated that the DNA breakage is induced by reactive 
oxygen species (ROS) derived from the reduction of Cu(II)–Cu(I) by these 
polyphenols (Azmi et al., 2006). 
 
2.6.2 Possible interactions between resveratrol and Zn 
Resveratrol has been shown to extend the lifespan of diverse species, 
including S. cerevisiae, C. elegans and D. melanogaster, and was found to be 
dependent on the Sir2 protein, which belongs to the sirtuin/Sir2 family of NAD+-
dependent deacetylases (Howitz et al., 2003; Wood et al., 2004; Viswanathan et al., 
2005). Seven mammalian sirtuin genes, SIRT1 to 7, have been identified and 
implicated in genomic stability, transcriptional regulation, mitochondrial regulation 
and life span extension (Blander and Guarente, 2004).  They catalyse the removal of 
acetyl groups from lysine amino acids of histones and transcription factors (p53 and 
forkhead transcription factors). In mammalian cells, resveratrol induces SIRT1 
expression, which modulates glucose and insulin production, fat metabolism, and cell 
survival (Kolthur-Seetharam et al., 2006; Frescas et al., 2005). Recently, dietary 
intakes of 5.2 and 22.4 mg/kg/day of resveratrol, which were considered to be 
feasible daily doses for humans by the reporting researchers, were shown to shift the 
physiology of middle-age mice on a high caloric diet towards that of mice on a 




et al., 2006). In addition, reduced insulin-like growth factor-1 level as well as 
enhanced AMP-activated protein kasinase and PPAR-γ coactivator 1α activity were 
observed. The authors specified that the dosages used are feasible daily doses for 
human. Within the SIRT protein, a novel zinc ribbon motif that binds zinc was found 
to be essential for catalytic activity. Thus, an increase in zinc ion concentration would 
enhance enzyme activity for a pool of SIRT proteins lacking this required zinc ions. 
Interestingly, a recent study demonstrated that the sirtuin pathway is involved in Zn(II) 
toxicity in mice cortical neuron cells in culture (Cai et al., 2006). Other cellular 
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CHAPTER III: ANTICANCER EFFECT OF TRIFOLIRHIZIN 
IN HUMAN PROSTATE CELLS 
3.1 Abstract 
Trifolirhizin, found in the roots of Sophora flavescens, a traditional medicinal 
plant widely used in Asia, is a potent polycyclic flavonoid with anticarcinogenic 
effects. To elucidate the mechanisms underlying the anticancer activities of 
trifolirhizin, the effect of trifolirhizinon on the inhibition of cell cycle progression, 
induction of apoptosis and regulation of tumor suppressor gene expression was 
examined in human derived prostate cancer cells LNCaP and PC-3 as well as normal 
human prostate epithelial cells (NHPrE). The treatment of as low as 25 μM 
trifolirhizin in LNCaP cells for 6 days resulted in 40% inhibition of cell proliferation.  
Treatment of higher dosages caused the growth inhibition effect to be manifested in 
as early as 3 days. PC-3 cells were not affected by trifolirhizin till the very high 
dosage of 125 μM that resulted in more than 50 % reduction in cell proliferation after 
4 to 6 days of treatment. Most importantly, for normal human prostate epithelial 
(NHPrE) cells, trifolirhizin was effective only at the highest concentration of 200 µM. 
The growth inhibition in trifolirhizin treated LNCaP and PC-3 cells was associated 
with cell cycle arrest at the G0/G1 and G2/M phase, respectively, in a dosage 
dependent manner. Moreover, the protein expression of cyclin E was unchanged but 
that of cyclin D1, p53 and p21 was suppressed in 50 μM trifolirhizin treated LNCaP 





3.2.1 Project summary 
This project investigated the anticancer activity of trifolirhizin, an active 
component of Sophora flavescens, a traditional medicinal plant widely used in Asia. 
The effect of trifolirhizin on the inhibition of cell cycle progression, induction of 
apoptosis and regulation of tumor suppressor gene expression was examined in 
human derived prostate cancer cells LNCaP and PC-3. In response to the lack of 
experimental data on the effect of most natural plant products on normal cells in 
primary cultures, similar experiments were performed in normal human epithelial 
prostate cells (NHPrE). The cytotoxic effect and cell cycle progression inhibition 
effect of these products on different cell lines were determined by a MTS assay and 
flow cytometry, respectively. The expression of tumor suppressor genes under the 
treatment of different concentration of trifolirhizin was determined by Western 
blotting or flow cytometry using fluorescence labeled antibodies. Data generated 
from this research will contribute to the understanding of molecular mechanism(s) of 
the anticancer role of this plant derived natural product and specifically aid in the 
discovery of new effective compounds as potential anticancer chemopreventive and 
chemotherapeutic agents of plant origin. 
3.2.2 Significance and rationale 
For the first time, we undertook a detailed research on the sensitivity of 
prostate cancer cells to trifolirhizin by using an in vitro cell culture system including 




null (PC-3) cells. In view of the lack of previous experimental data from 
corresponding normal control cells and the necessity of identifying the agents that can 
eradicate cancer cells without causing toxic responses in uninvolved normal cells, we 
also included the normal human prostate epithelial (NHPrE) cells in the present study 
as a control. We show that trifolirhzin exerts its antiproliferative effect against both 
androgen-dependent and androgen independent human prostate cancer cells at a 
dosage and time dependent manner and that this effect is mediated through 
interference of cell cycle progression without signs of apoptosis induction. Our study 
also sheds light on the molecular mechanism by which trifolirhizin inhibits cell cycle 
progression in prostate cancer cells. Under the conditions used in this study, 
trifolirhizin in moderately high concentrations did not affect the viability of normal 
prostate epithelial cells. 
3.3 Materials and Methods 
3.3.1 Preparation of trifolirhizin 
That pure compound, trifolirhizin was isolated, purified, identified and kindly 
provided by Dr. Linagli Yu’s lab. Briefly, a methanol extract of the root of Sophora 
flavescens was separated by silica gel column chromatography (CC) and eluted with a 
gradient composing of CHCl3-MeOH. The fraction of CHCl3-MeOH (5:1) was 
further purified by repeated silica gel CC to afford a purified compound. The 
compound was then identified as trifolirhizin (MW 446) by 1H, 13C NMR and ESI 
MS analysis, which was a known compound previously isolated from Sophora 




bottles filled with nitrogen. A stock solution of 100mM was made by dissolving 
trifolirhizin and in DMSO and stored at 4 oC. 
3.3.2 Cell culture 
Human prostate carcinoma cell lines LNCaP, PC-3 were purchased from the 
American Type Culture Collection (Manassas, VA). The normal prostate epithelial 
(NHPrE) cells from a 29-year old Caucasian male were purchased from Lonza 
Walkersville, Inc. (Walkersville, MD). The prostate cancer cells were cultured as 
monolayers in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine 
serum (Invitrogen), 100 μg/mL penicillin, and 100 μg/mL streptomycin (Invitrogen, 
Carlsbad, CA) and maintained in an incubator with a humidified atmosphere of 95% 
air and 5% CO2 at 37 oC. The normal human prostate epithelial (NHPrE) cells were 
cultured in Prostate Epithelial Cell Growth Medium (PrEGM) purchased from Lonza 
Walkersville, Inc. and maintained in an incubator under the conditions described 
above. In all treatments, tested drugs were dissolved in a small amount of vehicle 
(DMSO) with maximum concentration 0.2% (V/V). Cells treated with same amount 
of vehicle only were used as controls. 
3.3.3 Cell proliferation assay 
The effect of trifolirhizin or SFE on the proliferative capacity of cells was 
determined using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay 
(Promega, Madison, MI), according to the procedures recommended by the 
manufacturer. Briefly, cells (2500 cells /well) were seeded in a flat-bottomed 96-well 




and cells were treated with 100 μL fresh culture medium with different concentrations 
(0, 1, 5, 10 and 50 μg/mL for SFE or 0, 5, 10, 25, 50, 100, 200 μM for trifolirhizin) of 
tested candidate for 2d, 3d, 4d and 6d with 5 replicates. At the end of exposure period, 
20 μL of Cell Titer 96 aqueous solution were added to each well and bioreduced by 
the dehydrogenase enzymes in metabolically active cells into a formazan product. 
After 1 h incubation in a humidified atmosphere at 37 oC, the quantity of formazan 
product, which is directly proportional to the number of living cells in culture, was 
measured by the amount of absorbance at 490 nm. The blank was recorded by 
measuring the absorbance at 490 nm with wells containing medium but no cells. 
Results of the treatment groups were expressed as percentage of their respective 
control set at 100%. 
3.3.4 Cell cycle analysis 
Subconfluent cells were treated with trifolirhizin in culture medium as 
described above for various periods and then harvested at just below 70% confluency, 
washed with cold PBS and processed for cell cycle analysis. Briefly, 1 X 106 cells 
were aliquoted in 50 mL polypropylene centrifuge tube, washed in 3 mL 1X in PBS 
(no Ca or Mg) and resuspended in 1.5 mL PBS.  To these resuspended cells, 15 mL of 
70% ethanol were added and mixed gently by vortex.  Cells then were stored at 4 oC 
for 4 h and then labeled with propidium iodide. A total of 10,000 cells were collected 
for DNA analyses on a FACScalibur cytometer with the CELLQuest program 
(Becton Dickinson, San Jose, CA) and the results were analyzed by ModFit LT 
(Version 3.0, Verity Software House, Topsham, ME). Calibration standards, 




(Becton Dickinson, San Jose, CA), were used to verify instrument performance. The 
DNA content of a cell population analyzed by this assay was used to determine the 
proportion of cells that were in G0/G1, S or G2/M phase of the cell cycle. 
3.3.5 Protein immunodetection   
Fixation and permeabilization steps were adapted from previously published 
methods (Chow et al., 2005; Krutzik and Nolan, 2003). Cells (2 X 106) were 
resuspended in 300 μL of RPMI medium. Thirty μL of formaldehye (16%) were then 
added to give a final concentration of 1.5% and cells were fixed for 15 min at room 
temperature followed by centrifugation. Pellets were re-suspended by vortexing in a 
small volume of RPMI (less than or equal to 50 μL). One mL of ice cold methanol 
was added to the chilled tube while again vortexing to prevent cell clumping. Samples 
were capped tightly and stored at -20 oC until analysis by flow cytometry (7-10 days) 
using appropriate fluorescence-labeled antibody. 
3.3.6 Statistical analysis  
Data were presented as mean ± SEM. Statistical significance was examined by 
Student’s t test between control and treated group or a one-way ANOVA followed by 






3.4.1 The SFE is cytotoxic against NHPrE cells, while the purified 
compound trifolirhizin is not 
We first investigated the effect of SFE on the proliferation of normal human 
prostate epithelial cells. As shown in Fig. 1, proliferation or cell growth of NHPrE 
cells was reduced by 30 and 90%, when treated with fairly high levels of SFE at 10 or 
50 μg/ml, respectively, for 48 hours, which indicated a strong cytotoxicity in primary 
NHPrEs. Most importantly, the purified component trifolirhizin, prepared by column 
chromatography, was effective only at the very high concentration of 200 μM, which 
resulted in 20% and 35% reduction in cell growth after a prolonged treatment of 4 
and 6 days. Lower dosages (5, 10, 25, 50 and 100 μM) and short treatment periods (2 




























Figure 1. The effect of methanol extract from Sophora flavescens (SFE) on the 
proliferation of NHPrE cells. The NHPrE cells (5000/well) were plated in 96-well 
plates with different concentrations of SFE for 48 hours. Viable cell density was 
determined by the CellTiter 96 Aqueous One Solution Cell Proliferation Assay as 
described in Material and Methods. Results are expressed as percentage of control set 
at 100%. Values are means ± SEM from 5 separate experiments. Different letters 
indicate significant differences among groups (p<0.05); treatments with the same 










































Figure 2. The effect of trifolirhizin on the proliferation of NHPrE cells. The 
NHPrE cells (2500/well) were plated in 96-well plates with different concentrations 
of trifolirhizin for different periods. Viable cell density was determined by the 
CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega) as described 
in Material and Methods. Results are expressed as percentage of control set at 100%. 
Values are means ± SEM from 5 separate experiments. Different letters indicate 
significant differences among groups (p<0.05); treatments with the same letter 




3.4.2 Trifolirhizin treatment significantly inhibits the proliferation 
of LNCaP and PC-3 prostate cancer cells in dose and time-
dependent manner 
In LNCaP cells, which are androgen responsive and represent early stage 
prostate cancer, there was a strong dosage and time dependent response to the 
treatment of trifolirhizin. The lowest effective level of Trifolirhizin at 25 μM reduced 
cell proliferation by 40% after 6 days of treatment. Any concentration lower than that 
was not effective (Fig 3A). Thereafter, Trifolirhizin was able to reduce proliferation 
consistently at higher level of 50, 100 or 200 μM (Fig. 3A), with stronger effect at 
higher concentrations. The highest dosage, 200 μM was found effective as early as 
after 2 days of treatment, resulting in approximately 20% reduction in cell growth. 
Only 40% and 20% LNCaP cells could survive after treated for 6 days at 100 and 
200μM trifolirhizin. On the other hand, PC-3 cells, which are androgen non-
responsive, representing late stage cancer, were not affected by trifolirhizin till the 
very high dosage of 100 μM that resulted in an average of 15% reduction among the 
incubation times, a slight increase of the dose to 125 μM gave more than 40 % 
reduction in cell proliferation after 4 to 6 days of treatment (Fig. 3B). However, there 
was no significant difference between the 3 concentrations 125, 150 and 175 μM in 
each term of antiproliferative effects in each incubation period. In addition, Pc-3 cells 
manifested lag of 2 days in response to the treatment of trifolirhizin, , as indicated by 




concentration. The highest concentration 200 μM resulted in about 50% reduction in 
























































































Figure 3. The effect of trifolirhizin on the proliferation of LNCaP and PC-3 cells. 
The LNCaP cells (A) and PC-3 cells (B) were plated at a density of 2500/well in 96-
well plates with various concentrations of trifolirhizin for different periods. Viable 




Proliferation Assay (Promega) as described in Materials and Methods. Results are 
expressed as percentage of control set at 100%. Values are means ± SEM from 5 
separate experiments. Different letters indicate significant differences among groups 




3.4.3 Trifolirhizin treatment induced cell cycle arrest at G1/G0 and 
G2/M stage in LNCaP and PC-3 cells, respectively 
The significant antiproliferation effect of trifolirhizin led us to investigate the 
cell cycle distribution of trifolirhizin treated LNCaP and PC-3 cells and we observed 
no induction of apoptosis in both cancer cell lines. However, for the first time, our 
result revealed that the inhibition of proliferation in trifolirhizin treated LNCaP and 
PC-3 cells was associated with a cell cycle arrest at the G0/G1 starting at the 
treatment of 25 μM (Fig. 4A and 4B) and G2/M phase at that of 125 μM (Fig. 4C 
and 4D), respectively, in a dosage dependent manner. No sign of apoptosis was 
observed in the trifolirhizin treated LNCaP and PC-3 cells, as indicated by the little 
number of cells in the sub G0/G1 (Apo) region, representing hypodiploid apoptotic 
cells even at the highest levels (100 uM in the case of LNCaP and 175 μM in the case 
of PC-3), indicating that under the experimental dosages, trifolirhizin can only cause 



































































































Figure 4. The effect of trifolirhizin on cell cycle progression of LNCaP and PC-3 
cells. The LNCaP cells (2.5X105/well) (A and B) and PC-3 cells (1.3X105/well) (C 
and D) were plated in 6-well plates with different concentrations of trifolirhizin for 5 
days. The cell cycle distribution of collected cells was determined by flow cytometry 
as described in Material and Methods. Open graphs (A and C) are the raw data from 
flow cytometry. The given result is a representative of three seperate experiments. 
Bar graphs (B and D) show DNA content at each phase of the cell cycle: G0/G1 
phase, S phase, and G2/M phase, calculated by the computer software, CELLQuest. 
Values are means ± SEM from 3 separate experiments. Only the phase with an 
increasing trend of cell number was tested for statistical significance. Different letters 
indicate significant differences among groups (p<0.05); treatments with the same 




3.4.4 Prolonged trifolirhizin treatment depressed p53, p21 and 
cyclin D1 expression, induced hypophosphorylated Rb expression 
and kept cyclin E level constant 
We further examined the molecular mechanism of trifolirhizin on cell cycle 
arrest by using LNCaP cells as a model. Five days (approximately one passage) of 
incubation time was chosen to mimick medium to long term period. The total 
intracellular protein levels of cyclin D1, E p53, p21 and hypophosphorylated Rb were 
assessed in 50 μM trifolirhizin treated LNCaP cells. A marked reduction 
(approximately 35%) in the expression of cyclin D1 (Fig. 5), while no change of 
cyclin E (Fig. 5) in trifolirhizin treated LNCaP cells was observed. Moreover, the 
treatment with 50 μM of trifolirhizin for 5 days suppressed p53 and p21 expression 
by 40% and 30% respectively and enhanced the hypophosphorylated Rb level by 50% 


































Figure 5. The effect of trifolirhizin on Cyclin D1, E, P53, P21 and 
hypophospholyrated Rb expression in LNCaP cells. The LNCaP cells 
(2.5X105/well) were plated in 6-well plates with 50 μM of trifolirhizin for 5 days. 
Collected cells were fixed in 1.6 % formaldehyde and finally resuspended in 
methanol before immunodetection using specific FITC labeled antibodies for each 
protein. Bar graph shows relative percentage of the increase in fluorescence (FL) 
produced by binding of the antibody specific to the protein compared to that produced 
by binding of the isotype control antibody. The FL increase for control was set to be 
100%. Data were calculated using a gate of 10,000 events (cells) for all samples and 
treatments. Trifolirhizin treated cells had a modest G0/G1 block (about 10%) in each 
experiment. Values are means ± SEM from 3 separate experiments. *, Student’s T 





Nowadays, it is still very common to screen for anticancer drugs or 
chemopreventive agents from candidates that are highly cytotoxic to cancer cells. 
However, the cytotoxic effect may not be specific for cancer cells and the side effects 
brought to the normal cells by these agents may be devastating as well. Thus, 
treatments involving the usage of these chemicals may impose detrimental effect on 
normal cells while inhibiting the growth of cancer cells, because the cancer cells and 
normal cells contain almost the same genetic background, which may be affected by 
these natural agents. Therefore, the search for better cancer chemotherapeutic agents 
with minimal side effects in normal human cells is still ongoing. In our study, a broad 
dosage range (25-200 μM) of trifolirhizin was found to exert anticancer activity 
against human prostate cancer cells (Fig. 3), while having little or no effect on the 
normal growth of healthy human prostate epithelial cells (Fig. 2). In 2004, 
Aratanechemuge et al. also reported that trifolirhizn at 270-360 μM does not induce 
apoptosis in normal lymphocytes prepared from healthy volunteers (Aratanechemuge 
et al., 2004). These data suggest that at a broad concentration range, trifolirhizin will 
not be harmful to healthy body tissues. In fact, many plants store important defensive 
chemicals in the forms of inactive glycosides and render them available quickly by 
hydrolysis that breaks off the sugar part from the main chain of the chemical. 
Maackiain, another phytochemical with one glycoside side chain less than 
trifolirhizin in structure, was isolated from the same extract and reported to be 5 times 
stronger than trifolirhizin (maackiain glycoside) in terms of growth inhibition and 




lymphocytes (Aratanechemuge et al., 2004). These characteristics exhibited by 
maackiain makes it a promising candidate of antitumor chemopreventive agent and 
the effect of maackiain on prostate cancer cells LNCaP and PC-3 as well as NHPrE 
cells will be investigated in our lab as a separate project.  
We reported cell cycle arrest at G0/G1 and G2/M stage in trifolirhizin treated 
LNCaP and PC-3 cells, respectively (Fig. 4). It is intriguing that the same compound 
induces cell cycle arrest at different phase in different cell type. Similarly, berberine 
has been documented not only induce G0/G1 cell cycle arrest in human prostate 
cancer DU145 cells, but also induce G2/M cell cycle arrest in human gastric 
carcinoma SNU-5 cells. Although in our studies, LNCaP and PC-3 are both prostate 
cancer cell lines, representing different states of prostate cancer, the observation of 
cell cycle arrest induced at different phases may be due to the interaction between the 
agent and the genetic background of cell lines or the different stage of cancer 
development. 
In general, cell cycle control is a multigenic regulatory network. Therefore, 
we assessed the protein expression level of several target genes that might be 
involved in the trifolirhizin induced G0/G1 arrest in NHPrE cells. A proposed 
molecular mechanism of Trifolirhizin’s anticancer activity in LNCaP cells is 
indicated in Fig. 6. In the trifolirhizin treated NHPrE cells with a cell cycle arrest at 
the G0/G1 stage, the cyclin D1 expression is expected to be repressed since cyclin D1 
is the major effector that regulates the cell cycle transition from G0/G1 to S phase. In 
mammalian cells, two cyclin-CDK complexes, cyclin D-CDK4/6 and cyclin E-CDK2, 




respectively (Sherr, 2000). Both cyclin D-CDK4/6 and cycln E-CDK2 complexes can 
successively phosphorylate retinoblastoma protein (Rb) and lead to its inactivation 
(Harbour and Dean, 2000), which hinders the E2F-1/Rb association necessary for the 
expression of E2F-1-dependent genes needed for S phase entry (Leone et al., 2001). 
In our study, cyclin D1 expression was repressed while cyclin E expression was not 
changed, suggesting the signal was exclusively transmitted through cyclin D-CDK4/6 
complex. The suppressed cyclinD-CDK4/6 could no longer successively 
phosphorylate Rb, which leads to increased hypophosphorylated Rb level. Cyclin B is 
necessary for G2/M transition and for cells to enter mitosis by forming complex with 
Cdc-2. In trifolirhizin treated PC-3 cells with a G2/M arrest, the expression of cyclin 
B is very likely to be repressed as well when compared to the control. p53, a very 
important tumor suppressor gene, has been implicated in a variety of cellular 
processes, including induction of G1 arrest (Ciciarello et al., 2001) and maintenance 
of G2/M arrest in response to DNA damage (Bunz et al., 1998). In the cases of cell 
cycle arrest by plant natural product treatment, p53 upregulation was observed in both 
G0/G1 arrest (Chang et al., 2004; Wu et al., 2004; Meng et al., 2004; Lee et al., 1999) 
and G2/M arrest (Lin et al., 2006; Zhang et al., 2005), suggesting that p53 is a 
universal cell cycle regulator by transactivating a number of downstream genes. p21 
and p27, two Cip/Kip family members of the CDK inhibiors, are the transcription 
targets of p53 and play an important role in mediating G1 arrest by binding to the 
cyclin-CDK complexes and inhibiting their activities (Waldman et al., 1995; 
Pavletich, 1999). An upregulation in p53 protein or mRNA level in association with 




cancer cell lines has been observed in many studies, suggesting a p53 dependent 
pathway (Wu et al., 2004; Lee et al., 1999; Lin et al., 2006; Zhang et al., 2005). p21, 
as a downstream transcription target of p53, has also been found to be elevated 
concomitantly with p53 (Meng et al., 2004; Chang et al., 2004). On the other hand, 
p21 has also been demonstrated to regulate cell cycle progression and induce 
apoptosis independent of p53 (Chen et al., 2004). In our study, the concomitant 
suppression of p53 and p21 expression (Fig.  5) and the G2/M arrest in trifolirhizin 
treated, p53 null, PC-3 cells (Fig. 4) suggested that the proliferation inhibition and 
cell cycle arrest effect caused by trifolirhizin treatment in LNCaP and PC-3 cells was 
probably through a p53 independent pathway. Akt, also known as Protein Kinase B 
(PKB), may be a potential regulator that is responsible for the concomitant 
downregulation of the p53 and p21 levels through the Akt-Mdm2-p53 signaling axis 
and Akt-p21 signaling axis. The phosphorylated form of Akt (p-Akt) has been shown 
to physphorylate Mdm2 at Ser 166 and 186 residues (Gottlieb et al., 2002), which are 
close to Mdm2’s nuclear localization signal and nuclear export signal domains. The 
pAkt mediated physphorylation of Mdm2 (p-Mdm2) leads to its translocation from 
cytoplasm to nucleus and further interaction with p53 and p300, which then promotes 
the ubiquitin-dependent degradation of p53 (Mayo and Donner, 2001). As a result, 
Akt indirectly hinders p53-dependent growth suppression and apoptosis. On the other 
hand, the function of p21 may dichotomize depending on its cellular localization. In 
the nucleus, p21 acts as a CDK inhibitor that arrests the cell cycle and blocks DNA 
sythesis. When localized in the cytoplasm, p21 is pro-proliferative and promotes cell 




from cytoplasm to nucleus can be prevented by phosphorylation mediated by p-Akt at 
Thr145 residue, which lies near the nuclear localization signal (NLS) domain (Zhou 
et al., 2001).  Thus, the cytoplasmically retained p21 can facilitate and stabilize the 
cyclin D-CDK4 complex (Boonstra, 2003). This may partially explain the observation 
that no sign of apoptosis occurred in the trifolirhizin treated LNCaP and PC-3 cells. 
However, more studies, such as p53 time course expression and p53 knock down in 
LNCaP (p53+/+) cells as well as p53 transfection in PC-3 (p53-/-) cells, need to be 
conducted to thoroughly investigate the  p53 dependency in the trifolirhizin-induced 
proliferation inhibition and cell cycle arrest effect in LNCaP and PC-3 cells. 
3.6 Conclusion 
In conclusion, these findings demonstrate that trifolirhizin exerts its antitumor 
activity by the inhibition of proliferation mediated by triggering cell cycle arrest at 
G0/G1 and G2/M stage in LNCaP and PC-3 cells, respectively. The cell cycle arrest 
was mediated by the depressed expression of corresponding cyclins, possibly through 
a p53 and p21 independent pathway (Fig. 6). The antitumor effect of trifolirhizin was 
exclusively against cancer cells LNCaP and PC-3 and under our experimental 
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Figure 6. Proposed molecular mechanism of Trifolirhizin’s anticancer function 
in LNCaP cells. 
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CHAPTER IV: THE EFFECT OF RESVERATROL AND ZINC 
ON INTRACELLULAR ZINC STATUS IN NHPrE CELLS 
4.1 Abstract 
To evaluate the influence of resveratrol on cellular zinc status, normal human 
prostate epithelial (NHPrE) cells and human hepetoblastoma (HepG2) cells were 
treated in 6 levels of resveratrol (0, 0.5, 1, 2.5, 5 and 10 μM) and 4 levels of zinc [0, 4, 
16 and 32 μM or zinc deficient (ZD), zinc normal (ZN), zinc adequate (ZA) and zinc 
supplemented (ZS), respectively]. Among each zinc treatment, a progressive 
reduction in cell growth or increase in cellular total zinc was observed with increases 
of resveratrol from 2.5, 5 and 10 μM or from 5 and 10 μM, respectively. Moreover, in 
ZS cells, a much higher increase in cellular total zinc was observed as early as 1 μM 
resveratrol. In contrast, resveratrol exerted no effect on cell growth and cellular zinc 
level in HepG2 cells. A flow cytometry study revealed that the resveratrol (10 μM) 
induced G2/M arrest was responsible for the depressed cell growth in NHPrE cells. 
Data from an in vitro experiment using zinquin, as an indicator of intracellular free 
Zn(II) status, demonstrated possible complex formation between resveratrol and zinc 
ion. Zinquin ethyl ester fluorescence spectrofluorimetry and microscope imaging 
revealed that intracellular labile free zinc tended to be decreased in ZD and ZN 
NHPrE cells but increased in high zinc (ZA and ZS) cells. In addition, the abundance 
of metallothionein (MT) mRNA was markedly elevated only in ZS cells, with or 




transcription factor-1 (MTF-1) mRNA abundance. Furthermore, increases in cellular 
zinc status induced enhanced levels of reactive oxygen species (ROS) as well as 
senescenece detected by morphological and histochemical changes in cells treated 
with 2.5 or 10 μM resveratrol, especially in ZA and ZS cells. These findings support 
the contention that the reduction in cell growth and G2/M arrest induced by 
resveratrol treatment may be modulated by the marked increase in intracellular total 







4.2.1 Project summary 
Resveratrol has been shown to chelate divalent cations. We hypothesize that at 
low mineral status, resveratrol enhances zinc, copper (Cu), and selenium (Se) status 
by increasing their cellular uptake. However, at high mineral status, high resveratrol 
intake may cause excessive mineral deposition. We aim to evaluate the 
interrelationships of resveratrol with zinc, Cu, and Se in a mouse model and in normal 
human cells in culture. As part of my dissertation, my work was mainly focused on 
the in vitro studies designed to determine the interrelationship of resveratrol with zinc 
in NHPrE cells. NHPrE cells were cultured in six levels of resveratrol and four levels 
of metals (from none for resveratrol, or deficient for zinc, to the high end of plasma 
levels attainable by oral consumption in humans), in a 6X4 factorial design to assess: 
1) cell growth, cell cycle progression, apoptosis; 2) cellular total zinc and free labile 
zinc levels; and 3) in vitro possible interaction between zinc and resvervatrol.  
4.2.2 Significance and rationale 
Resveratrol is widely reported to have health promoting properties: 
cardiovascular, anti-inflammatory (Jang et al., 1997), antimutagenic (Uenobe et al., 
1997), antioxidant, and pro-oxidant activities (Azmi et al., 2006) as well as 
chemopreventive against various stages of chemically induced carcinogenesis (Jang 
et al., 1997). In the US and Europe, resveratrol is commercially available as a 




and cell culture studies, as well as human long term studies, using dose response 
approaches to aid in the establishment of upper limits of intake are lacking. Thus, data 
generated by the cell-based studies will aid in establishing the effective minimum 
dose for certain biological activities and contribute to the setting of upper limits for 
resveratrol. Data generated may support the need to revise the upper limit for zinc if 
excessive zinc deposition is detected in NHPrE cells. 
In recent studies, resveratrol was established to exert its pro-oxidant activity 
of oxidative DNA breakage for its anticancer properties (Azmi et al., 2006). In 
addition, resveratrol was shown to be a potent chelator of Cu but it did not chelate Fe 
(Belguendouz et al., 1997). Moreover, resveratrol administration has been shown to 
markedly increase plasma zinc and Cu in adult rats (Kavas et al., 2007). Furthermore, 
our preliminary NHPrE cell culture studies demonstrated that resveratrol is capable of 
inhibiting cell proliferation and markedly enhancing cellular zinc level in normal 
human prostate epithelial cells maintained under various zinc status. Thus, resveratrol 
may alter the metabolism and requirement of these trace minerals. In this project, the 
impact of resveratrol and zinc as well as the interactions of resveratrol with zinc were 
examined in NHPrE cells. Data generated in this study will contribute to the 
development of biomarkers for the measurement of health outcomes for the bioactive 
resveratrol, together with its nutritional interactions with zinc, and aid in the setting of 
dietary reference intakes and tolerable upper limits for resveratrol and zinc, as well as 
in the design of clinical studies for further exploration of the interaction between 
resveratrol and zinc in human subjects. More importantly, this study involving 




of the impact of the interaction between other trace minerals such as Cu and Se and 
bioactive resveratrol in normal human cells derived from a wide range of human 
tissues, e.g. normal human bronchial epithelial cells (NHBE), normal human aortic 
epithelial cells (NHAE), which may behave differently due to tissue specificity. 
4.3 Materials and Methods 
4.3.1 Materials 
Resveratrol, ZnSO4 (1 M) solution, zinquin and zinquin ethyl ester were 
purchased from Sigma-Aldrich Co. (St. Louis, Mo). Resveratrol, zinquin and zinquin 
ethyl ester were dissolved in dimethyl sulphoxide (DMSO) at a concentration of 20 
mM, 25 mM and 25 mM, respectively, and stored at -20 oC.  
4.3.2 Experimental design  
A factorial design involving six (6) levels of trans-resveratrol (0, 0.5, 1, 2.5, 5 
and 10 µM; from none to the high end of plasma levels attainable by oral 
consumption in humans) and four (4) levels of zinc [<0.4, 4, 16 and 32 µM, which 
represent deficient (ZD); as in most culture medium (ZN); normal plasma level (ZA); 
and the high end of plasma level attainable by oral consumption in humans (ZS), 
respectively] were used in the investigation of the effect of zinc and resveratrol on the 
proliferation and intracellular total zinc level of NHPrE and HepG2 cells. A 
simplified experimental design involving 4 levels of zinc and 2 or 3 levels of 




4.3.3 Cell culture 
NHPrE cells from two different donors (21-year old and 29-year old male 
Caucasian) were purchased from Lonza Walkersville, Inc. (Walkersville, MD). The 
NHPrE cells used in the experiments in this dissertation are from the 29-year old male 
Caucasian for consistency except otherwise indicated.  NHPrE cells were plated at 
2,500 cells/cm2 in tissue culture dishes containing prostate epithelial cell growth 
medium (PREGM), supplemented with 0.5 µg/mL epinephrine, 10 µg/mL transferrin, 
5 µg/mL insulin, 0.1 ng/mL retinoic acid, 52 µg/mL bovine pituitary extract, 0.5 
µg/mL hydrocortisone, 0.5 pg/mL human recombinant epidermal growth factor, and 
6.5 ng/mL triiodothyronine (as growth supplements) without antibiotics, and cultured 
at 37°C in a 5% CO2 incubator. Endotoxin-free medium were used (<0.005 endotoxin 
units/mL). The medium were changed at day 1 and subsequently every 48 h. Cells 
were grown to 80% confluence for 6 days, and subcultured using trypsin-EDTA at a 
ratio of 1: 8 at passage 3 for experimental treatment. A zinc-free Prostate Epithelial 
Basal Medium (PREBM w/o zinc), in which the manufacturer had omitted the 
addition of ZnSO4, were used as the zinc-depleted medium after supplemented with 
necessary growth components and contains residual amounts of zinc (<1 μM), as 
detected by flame atomic absorption spectrophotometry. For the other zinc treatment 
groups, zinc was added to the media in the form of ZnSO4 so that the only difference 
between these media was the zinc concentration. The zinc-normal (ZN), the zinc-
adequate (ZA), and the zinc-supplemented (ZS) medium, will contain 4 μM, 16 μM, 
and 32 μM ZnSO4, respectively. The ZA treatment was used as a representative of 




plasma zinc levels attainable by oral supplementation in humans (Fanzo et al., 2001). 
Resveratrol in 0.05% DMSO was added to each level of zinc medium to generate the 
0, 0.5, 1, 2.5, 5 and 10 µM of resveratrol. The ZN medium without resveratrol was 
used as the control group for comparison with other treatments. Cells were cultured 
overnight in normal PREGM before changing to their respective treatment medium.  
The HepG2 cells purchased from the American Type Culture Collection 
(Manassas, VA) were cultured at 25000 cells/cm2 in DMEM supplemented with 10% 
FBS and appropriated antibiotics. Chelex 100 ion exchange resin (Bio-Rad, Hercules, 
CA) was used to deplete zinc from FBS. Briefly, the resin was first neutralized to 
physiological pH with 0.25 M HEPES, pH 7.4 before mixed with FBS at a ratio 1:4 at 
4 oC for 2h. The Chelex 100 resin was then separated from FBS by centrifugation 
followed by fitration through a 0.22 μm filter for sterilization and removal of residual 
Chelex 100 resin. Chelated FBS has a zinc concentration < 1.0 μM, as determined by 
flame atomic absorption spectrophotometry (Hitachi, San Jose, CA). The basal 
DMEM medium with 10% chelated FBS containing < 0.1 μM zinc was termed zinc-
deficient (ZD) medium. For the other zinc treatment groups (ZN, ZA and ZS), zinc 
was added to the media in the form of ZnSO4 as described in the previous paragraph. 
Resveratrol in DMSO was added to each level of zinc medium to generate the 0, 0.5, 
1, 2.5, 5 and 10 µM of resveratrol. The ZN medium without resveratrol was used as 
the control group for comparison with other treatments. Cells were cultured overnight 




4.3.4 Cell proliferation and total intracellular zinc assay 
An aliquot (100 µL) of the collected samples was used for total cell count 
determination by the NucleoCounter using the Nucleocassette Kit and NucleoView 
software (New Brunswick Scientific, Edison, New Jersey), according to the 
manufacturer protocol. Briefly, all cells were lysed and stabilized in the same volume 
of lysing and stablzing buffer and then 50 µL of lysed sample were sucked into a 
Nucleocassette and then scanned by the NucleoCounter, which features an integrated 
fluorescence microscope designed to detect signals from a fluorescent dye, propidium 
iodide, that intercalates to DNA in the nuclei of the lyzed cells. The rest of cells were 
then resuspended in 1.5 mL PBS and sonicated for two 30-second intervals on ice. 
Cellular zinc content was measured by flame atomic absorption spectrophotometry 
(Model 5000, Perkin Elmer, Norwalk, CT) using standard curves of 0.05-1.0 ppm 
generated with certified zinc reference solutions (Fisher Scientific, Fair Lawn, NJ) as 
previously described (Reaves et al., 2000). Furthermore, the certified zinc solutions 
were compared to Bovine Liver Standard Reference (US Department of Commerce, 
National Insitute of Standards, Gaithersburg, MD). Appropriate blanks were 
employed for all measurements. Cellular zinc was calculated as ng per million cells. 
4.3.5 Cell cycle analysis 
Subconfluent cells were treated in different culture media as described above 
for 3 days and then harvested at just below 70% confluency, washed with cold PBS 
and processed for cell cycle analysis. Briefly, 1.5 X 106 cells were aliquoted in 50 mL 




resuspended in 1.5 mL PBS.  To these resuspended cells, 15 mL of 70% ethanol was 
added and mixed gently by vortex with cap on tube.  Cells will then be stored at 4 oC 
for 2 to 4 h or overnight and then labeled with propidium iodide. A total of 10,000 
cells were collected for DNA analyses on a FACScalibur cytometer with CELLQuest 
program (Becton Dickinson, San Jose, CA) and the results were analyzed by ModFit 
LT (Version 3.0, Verity Software House, Topsham, ME). Calibration standards, 
LinearFlow Green (Molecular Probes, Carlsbad, CA) and DNA QC Particle Kit 
(Becton Dickinson, San Jose, CA), were used to verify instrument performance. The 
DNA content of a cell population analyzed by this assay was used to determine the 
proportion of cells that are in G0/G1, S or G2/M phase of the cell cycle. 
4.3.6 In vitro assay for zinc and resveratrol interaction  
Experiment 1: 100 µL of PBS, containing the full combination of different 
concentrations of zinc (0, 2, 4, 6, 8, 16, 24, or 32 µM) in the form of ZnSO4 and 
resveratrol (0, 5, 10 or 20 µM), were aliquoted into a 96-well plate in triplicates and 
then mixed with 25 µM zinquin.  
Experiment 2: 100 µL of PBS, containing the full combination of different 
concentration of zinc (0, 2, 4, 6, 8, 16, 24, or 32 µM, final concentration) and zinquin 
(5 or 25 µM) were aliquoted into a 96-well plate in triplicates and then mixed with 
(10 µM) or without resveratrol. 
 The plates were incubated in 37 oC for 5 min before the fluorescence signal 
from each well was quantitated at an excitation wavelength of 340 nm and emission 





4.3.7 Determination of labile level of free intracellular zinc 
Free intracellular zinc was measured to see if increases in resveratrol in the 
medium would lead to elevations in free intracellular Zn(II), which has been 
suggested to depress cell proliferation but not induce apoptosis in normal cells. 
Zinquin ethyl ester was used to quantify labile level of free intracellular Zn(II) by 
spectrofluorimetry using a method adopted from Zalewaki et al. (1993) and Coyle et 
al. (1994) with slight modification. At the end of treatment, 100 µL suspended cells at 
a concentration of 1 X 106 /mL were transferred to a 96-well optical plate (Nunc A/S). 
Zinquin was added to cells at a final concentration of 25 µM in PBS and incubated for 
30 min before the fluorescence readings were measured at an excitation wavelength 
of 340 nm and emission wavelength of 460 nm in a Genios Pro spectrophotometer 
(Tecan Group Ltd., Männedorf, Switzerland). Fluorescence of unloaded cells (caused 
by autofluoresence and light scattering) was subtracted from the readings to provide 
the zinquin-dependent fluorescence.  
4.3.8 Quantitative real time PCR (Q-RT PCR) 
Treated cells were washed in PBS for 3 times before being lysed in the plate 
with TRIzol reagent (Invitrogen Corp. Carlsbad, CA) for RNA extraction according 
to the manufacturer’s instruction. The isolated total RNA were quantitated by 
spectrophotometry using a SPECTRAmax Plus spectrophotometer (Molecular 
Devices, Sunnyvale, CA) and 1 µg of  total RNA was used for cDNA synthesis in a 
20 µL system with an AffinityScript Multiple Temperature cDNA synthesis Kit 




0.5 µL of the 20 µL cDNA product was used in a 25 µL RT-PCR reaction system as 
template and amplified by Taqman PCR Master Mix (Applied Biosystems, Foster 
City, CA) according to manufacturer’s instruction. Primers and probe sets for RT 
PCR for MTF-1 (Assay ID Hs00232306_m1) and GAPDH (Assay ID 
Hs99999905_m1) were purchased from the TaqMan Gene Expression Assays of 
Applied Biosystems (Foster City, CA) and the assays were carried out according to 
the manufacturer’s instruction. The Primers and probes sets for detecting total MT 
were synthesized by Applied biosystems (Foster City, CA) as a custom order because 
no single common amplicon region was found for all the 8 MT isoforms, MT1H, -
1H-like, -1G, -1L, -1E, -1A, and MT2, most highly expressed in human mononuclear 
cells (Cousins et al., 2003). A combination of two forward primers, two reverse 
primers and two Taqman probes was used to amplify all the 8 MT isoforms in one 
single assay. For this assay, the concentration for the four primers was at 450nM each, 
and that for the two probes was each at 125 nM. The Primer/probes for MTF-1, Total 
MT and GAPDH are shown in Table 1. Q-RTPCR was performed with a 
polymerase-activating step of 95 oC for 10 min, followed by 40 cycles of 95 oC for 15 
s and 60 oC for 1 min, and 95 oC for 15 s. The real-time fluorescent signal was 
detected and quantitated by an ABI PRISM 7000 Sequence Detection System 





Table 1. Sequences of primers and probes for quantitative RT-PCR 
Name Sequences  
hMT1, 2 Forward: 5’ GCACCTCCTGCAAGAAAAGCT 3’ 
Probe 5’ FAM CACAGCCCACAGGGCAGCAGG BHQ1 3’ 
Reverse: 5’ GCAGCCTTGGGCACACTT 3’ 
hMT1, 2 Alt Forward: 5’ GCACCTCCTGCAAGAAGAGCT 3’ 
Probe: 5’ FAM CACAGCCCACAGGACAGCAGG BHQ1 3’ 
Reverse: 5’ GCAGCCCTGGGCACACTT 3’ 
GAPDH Forward: 5’ Assay ID Hs99999905_m* 
Probe: 5’ FAM GGAAAAGCCATTTCGGTGCGATCAC NFQ 3’ 
Reverse: 5’ Assay ID Hs99999905_m* 
MTF-1 Forward: 5’ Assay ID Hs00232306_m1* 
Probe: 5’ FAM TTGGGCGCCTGGTCACCAGGGCTGC NFQ 3’ 
Reverse: 5’ Assay ID Hs00232306_m1* 
 
*Primer sequences for the Taqman Gene Expression Assays are confidential 




4.3.9 Cell morphology and fluorescence microscopic imaging 
Cells were cultured in Nunc Lab-Tek II Chamber Slide (8 wells) and treated 
accordingly as described above for 3 days. Morphological pictures of live cells were 
taken under a microscope before further experimental procedures. Cells were then 
washed three times in PBS, before fixation by the addition of 3.7% formaldehyde to 
each well for 30 min at 37 oC. The fixed cells were washed three times with PBS, 
incubated with 25 µM of zinquin ethyl ester in PBS for 30 min at 37 oC, and then 
washed 3 times with PBS. A coverglass was mounted on top of the slide and Vaseline 
was used to seal the edge of the coverglasses to prevent evaporation. The slides were 
then placed under a Zeiss AxioObserver 100 fluorescence microscope for image 
acquisition. Fluorescence of individual cells was observed by using the filter cube set 
49 for DAPI (ex. 365nm, FT 395nm, em. 445nm). Photomicrographs for each 
treatment were taken using the same magnification scale (200X), exposure time (2s) 
within 10 min to avoid errors from the autofading of the fluorescence signal. 
4.3.10 Reactive Oxygen Species (ROS) assay  
NHPrE cells were cultured in Nunc Lab-Tek II Chamber Slide (8 wells) at 
7500 cells/well and treated accordingly as described above for 24 hours. A dye named 
5-(and-6)-chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA), a cell-permeant indicator for reactive oxygen species, was added into the 
medium at a final concentration of 10 µM. After incubation in 37 oC incubator for 30 
min, the chamber was then placed under a Zeiss AxioObserver 100 fluorescence 




using the filter cube set 43 for GFP (ex. 470nm/40nm, FT 495nm, em. 525/50nm). 
Photomicrographs for each treatment were taken using the same magnification scale 
(100X), exposure time (6ms) within 10 min to avoid errors from the autofading of the 
fluorescence signal. 
4.3.11 Senescence assay 
Senescence assay was conducted using a Senescence Detection Kit (MBL Co. Ltd., 
Woburn, MA) according to the manufacturer’s instruction. Briefly, NHPrE cells were 
cultured in 24-well plates with a density of 6000 cells/well and treated for 3 days. The 
culture medium was removed and the cells were washed once with PBS. The cells 
were then fixed in 0.25 mL of Fixative Solution at room temperature for 10 min. 
After another wash with PBS, the cells were stained in 250 µL 1X staining solution 
containing 1mg/mL X-gal and 1X staining supplement for 12 hours. Cells were then 
overlayed with 70% glycerol and stored at 4 oC for storage or observed under a 
microscope for development of blue color. 
4.3.12 Statistical analysis 
Data were analyzed with SAS 9.1.3 windows software (SAS Institute Inc., 
Cary, NC) and presented as mean ± SEM. Student’s t test between control and treated 
group was employed in the cell cycle distribution analysis. A one-way ANOVA 
followed by least significant differences (LSD) was used to determine the statistical 
significance among treated groups and controls in other experiments. The level of 





4.4.1 Resveratrol is the major factor that inhibits the proliferation 
of NHPrE cells 
NHPrE cells were cultured in 6-well plates and treated in a 6X4 factorial 
design as described in Materials and Methods section 4.3.2 for 3 days before being 
collected and the total cell count was determined by the NucleoCounter using the 
Nucleocassette Kit and NucleoView software (New Brunswick Scientific, Edison, 
New Jersey), according to the manufacturer’s protocol. Cell growth of NHPrE cells, 
as determined by total cell number per plate, was markedly depressed by resveratrol 
but to lesser extent by zinc (Fig. 1A). After 3 days of culture, resveratrol treatement 
exerted little or no reduction in cell growth until the concentration reached 2.5 μM, 
which resulted in an average of 30 % reduction, as compared to no addition of 
resveratrol among all zinc treatments (Fig. 1A). Thereafter, a progressive reduction in 
cell growth was observed with the increase in resvertrol concentration to 5 and 10 μM 
among each zinc treatment. In general, there was little or no change in the pattern in 
cell growth reduction among zinc treatments, with the exception of lower cell growth 
in ZD and ZS cells as compared to ZN and ZA cells treated with no or 05 μM 
resveratrol. Similarly, Han (2007) has observed lower cell growth in ZD and ZS than 




4.4.2 Resvertrol significantly enhances total zinc level in NHPrE 
cells 
Total intracellular zinc content was measured using atomic absorption 
spectrophometry as described in Materials and Methods and then normalized with the 
cell number as the denominator. Resveratrol exerted little or no increase in cellular 
zinc level until 5 µM, as compared to no addition of resveratrol, among all zinc 
treatments. A further marked increase in cellular zinc level was observed with 10 µM 
resveratrol in each zinc treatment. In the ZD, ZN and ZA cells, a similar pattern of 
little or no change in cellular zinc status was observed among the no or low 
resveratrol treatments (0, 0.5, and 1 µM). However, in the ZS cells, as the resveratrol 
concentration was increased to 1, 2.5, 5 or 10 µM, dramatic increases of total cellular 


































































Figure 1. The effect of resveratral and zinc on the proliferation (A) and the total 
intracellular zinc level (B) of NHPrE cells. The NHPrE cells (25,000/well) were 
plated in 6-well plates and treated by 6 levels of resveratrol (0, 0.5, 1, 2.5, 5 and 10 
μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 3 days before being harvested. The 




Nucleocassette Kit and NucleoView software (New Brunswick Scientific, Edison, 
New Jersey), according to the manufacturer’s protocol. Cellular zinc status was 
determined by atomic absorption spectrophotometry. Nanogram of zinc per million 
cells was expressed to account for any differences in cell numbers between samples. 
Values are means ± SEM from 3 separate experiments. Different letters indicate 
significant differences among groups (p<0.05); treatments with the same letter 
indicate no significant difference. Similar results were observed using NHPrE cells 






4.4.3 Resveratrol does not affect the proliferation and intracellular 
zinc level of HepG2 cells, but zinc does 
Since the liver is an important organ responsible for heavy metal metabolism 
and storage, a similar experiment was carried out in HepG2 cells as in the NHPrE 
cells to investigate if resveratrol and zinc would affect the proliferation and 
intracellular zinc content in HepG2 cells. Zinc was found to be the only factor that 
actually affected the proliferation of HepG2 cells significantly, with about 20% cell 
number reduction in ZD cells and no change in ZA and ZS cells as compared to ZN 
cells (Fig. 2A). This observation confirmed previous findings from our lab (Wong et 
al., 2007). In addition, intracellular total zinc level in HepG2 cells increased 
progressively as the zinc level of the media increased from ZD to ZS, as observed in 
the past (Wong et al.,  2007). Resveratrol appeared to have no overall effect on cell 
proliferation and intracellular zinc content in HepG2 cells, since in each zinc group, 
the resveratrol treatments did not alter cell number and total zinc content. However, 
high levels of resvertraol (5 and 10 μM) tended to depress intracellular total zinc by 




































































Figure 2. The effect of resveratral and zinc on the proliferation (A) and the total 
intracellular zinc level (B) of HepG2 cells. The HepG2 cells (250,000/well) were 
plated in 6-well plates and treated by 6 levels of resveratrol (0, 0.5, 1, 2.5, 5 and 10 
μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 3 days before being harvested. The 




Nucleocassette Kit and NucleoView software (New Brunswick Scientific, Edison, 
New Jersey), according to the manufacturer protocol. Cellular zinc status was 
determined by atomic absorption spectrophotometry. Nanogram of zinc per million 
cells was expressed to account for any differences in cell numbers between samples. 
Values are means ± SEM from 3 separate experiments. Different letters indicate 
significant differences among groups (p<0.05); treatments with the same letter 




4.4.4 Resveratrol inhibits the proliferation of NHPrE cells by 
causing cell cycle arrest at G2/M stage, but not apoptosis 
We were very interested in the resveratrol-dependent inhibition of 
proliferation in NHPrE cells. Therefore, a cell cycle distribution study was perfomed 
to examine the influence of resveratrol (with or without 10 μM) in the ZN NHPrE 
cells. Treatment with 10µM of resveratrol caused 1.5-fold increase of the percentage 
of cells in G2/M phase (from 12% to 30%) compared to the controls, indicating an 
obvious G2/M arrest (Fig. 3B). No sign of apoptosis was detected in the control cells 
or cells treated with 10 µM resveratrol, as indicated by the clean Apo region observed 






































Figure 3. The effect of resveratrol on cell cycle progression of NHPrE cells. The 
NHPrE cells (25,000/well) were plated in 6-well plates with (10 µM) or without 
resveratrol under ZN condition for 3 days. The cell cycle distribution of collected 
cells was determined by flow cytometry as described in Material and Methods. Open 
graphs (A) are the raw data from flow cytometry. The given results are a 
representative of three seperate experiments. Bar graphs (B) show the percentage of 
cells at each phase of the cell cycle: G0/G1 phase, S phase, and G2/M phase, 
calculated by the computer software, CELLQuest. Values are means ± SEM from 3 
separate experiments. * depicts a significant increase in the percentage of cells in 




4.4.5 Resveratrol chelates zinc in vitro 
In the present study, the marked enhancement of  total intracellular zinc 
content, especially in ZA and ZS cells suggests that resveratrol may form a complex 
with Zn(II) at with Cu(II)and it is the complex that brings in most of zinc through a 
separate channel which is different from free zinc ion trafficking. Thus, to address 
this issue, an in vitro experimental system was designed to include 7 levels of Zn(II) 
(0, 2, 4, 8, 16, 24 and 32 µM),  in the form of ZnSO4, and 4 levels of resveratrol (0, 5, 
10 and 20 µM) in a 100 µL PBS. With the addition of zinquin, a membrane-
permeant fluorophore specific for Zn(II), the amount of free Zn(II) in the system 
was detected by the amount of fluorescence given out by the zinquin-Zn(II) complex. 
By keeping zinquin concentration constant at 25 µM, a dose-dependent decrease of 
fluorescence was observed along with increased concentration of resveratrol  at 4, 8, 
16, 24 and 32 µM Zn(II) (Fig. 4A). In addition, with different concentration of 
zinquin (5 or 25 µM), there was a significant decrease of fluorescent signal in 
treatment Res10 (resveratrol at 10 µM) compared to control Res0 (resveratrol at 0 
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Figure 4. The chelating effect of resveratrol for zinc. The experiments were carried 
out in a 100 µL PBS system with indicated concentration of components. The plate 




excitation wavelength of 340 nm and emission wavelength of 460 nm.Values are the 





4.4.6 Resveratrol enhances the effect of zinc supplementation on 
intracellular free labile zinc level  
Labile pool of intracellular zinc plays an important role in many cell activities. 
To investigate the effect of resveratrol on the intracellular labile zinc level, we used 
zinquin ethyl ester, which emitts much stronger fluorescent signal than zinquin (Fig. 
6), to visualize the free labile zinc pool under a fluorescence microscope as well as 
to quantitate free labile zinc level using spectrofluorimetry (Fig. 5). Zinquin-Zn(II) 
associated fluorescence was found to be deposited mainly in the secretary granules 
in the cytoplasm. Clear dark zone in the center of cells representing nuclei can be 
identified easily until loss of nuclear membrane (Fig. 6).  
Resveratrol treatment at 10 µM markedly increased intracellular free labile 
zinc status as measured by spectrofluorimetry in ZA and ZS cells by 52% and 49%,  
respectively, as compared to their corresponding controls with no resveratrol (Fig. 
5). In contrast, resveratrol treatment at 2.5 µM resulted in no increase in intracellular 
free labile zinc level in ZA and ZS cells (Fig. 5). Moreover, in ZD and ZN cells, 
resveratrol treatment at 2.5 or 10 µM exerted no effect on intracellular free zinc 
level (Fig. 5).  
The fluorescence microscopic results (Fig. 7) revealed a clear ascending trend 
of fuorescent signal for the ZD, ZN, ZA and ZS cells without the treatment of 
resveratrol (Fig. 7), indicating that the mediam zinc concentration and total 
intracellular zinc status positively affected intracellular free labile zinc level. As to 
the effect of resveratrol on the free labile zinc, increased fluorescent signal was 




corresponding controls treated without resveratrol. In addition, no difference in 
fluorescent signal was identified in ZD and ZN cells among the 0, 2.5 and 10 µM 
resveratrol treatments (Fig. 7). The fluorescence microscopic imaging results 






































Figure 5. The effect of resveratrol and zinc on intracellular free labile zinc status 
(by spectrofluorimetry). NHPrE cells were cultured in 6-well plates and treated by 3 
levels of resveratrol (0, 2.5 and 10 μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 
3 days before being collected. The total cell count for each sample was attained by the 
NucleoCounter using the Nucleocassette Kit and NucleoView software (New 
Brunswick Scientific, Edison, New Jersey), according to the manufacturer’s protocol. 
The final cell density of each sample was set to be 1 X 106/mL. An aliquot of 100 µL 
of each sample was transferred to a 96-well plate in triplicates and 25 µM of zinquin 
ethyl ester were added into each well. The fluorescent signal in each sample was 
normalized according to its own cell number and the one from ZNR0 was set to be 1. 









Figure 6. Comparison of cellular fluorescent signal by zinquin (A) and zinquin 
ethyl ester (B). NHPrE cells were cultured in ZN condition for 3 days in Nunc Lab-
Tek II Chamber Slide (8-well) before being fixed by 3.7% formaldehyde and stained 
by 25 µM zinquin or zinquin ethyl ester. After that, cells were observed under a 
fluorescent microscope with excitation wavelength at 365 nm, emission wavelength 
at 445 nm and magnification at 200X. Pictures on the left column show the cells 
under normal setting (no fluorescence), while pictures on the right show the cells 
under fluorescence settings (with fluorescence). Arrows indicate the location of 
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Figure 7. The effect of resveratrol and zinc on intracellular free labile zinc status 
(by fluorescence microscopic imaging). NHPrE cells were cultured in Nunc Lab-
Tek II Chamber Slide (8 wells) and treated by 3 levels of resveratrol (0, 2.5 and 10 
μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 3 days being fixed by 3.7% 
formaldehyde and stained by 25 µM zinquin ethyl ester for 30 min at 37 oC. After that, 
cells were observed under a fluorescent microscope with excitation wavelength at 365 
nm, emission wavelength at 445 nm and magnification at 200X. Pictures on the left 
column show the cells under normal setting (no fluorescence), while pictures on the 
right show the cells under fluorescence settings (with fluorescence). Shown images 




4.4.7 The effect of zinc and resveratrol on the MT and MTF-1 
mRNA abundance  
Metallothionein (MT), the major labile zinc bind protein, has been reported to 
be upregulated by zinc supplementation and positively correlated with the total and 
labile free intracellular zinc level under a range of zinc status from deficient to 
adequate. In view of the marked increase in total cellular zinc by resveratrol 
treatment, the abundance of MT and MTF-1 mRNA was measured to determine if 
they are affected by resveratrol treatment. Interestingly, MT mRNA level was only 
affected by cellular zinc status, and not by resveratrol (Fig. 8A). Without resveratrol 
treatment, the MT mRNA level of ZS cells was higher than ZD and ZN cells (Fig. 
8A). With 10 µM resveratrol treatment, the abundance of MT mRNA of ZS cells 
was higher than ZD, ZN and ZA cells. Moreover, there were no significant 
difference of MT mRNA abundance between the – Res and + Res treatment in all 4 
zinc groups.  In addition, both resveratrol and zinc treatment appeared to have little 





























































Figure 8. The effect of resveratrol and zinc on the total MT (A) and MTF-1 (B) 
mRNA abundance. NHPrE cells were cultured in 6-well plates and treated by 2 
levels of resveratrol (0 and 10 μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 3 
days before being collected. Total RNA were extracted from these cell samples and 1 
μg of extracted total RNA were reversely transcribed into cDNA. Q-RTPCR analyses 
were performed in triplicates. Relative quantity was established by using GAPDH as 
the endogenous normalization control. The mRNA level of ZN without resveratrol 




4.4.8 Resveratrol induces senescence in NHPrE cells through ROS 
generation 
Althought the NHPrE cells treated with resveratrol and zinc were not 
apoptotic, they all exhibited impaired proliferation, especially in 10 µM resveratrol 
treated cells at all zinc levels with only one population doubling in 3 days (Fig. 1A).  
The proliferation inhibition, but not apoptosis induction effect of resveratrol was 
highly likely to be mediated by the enhanced Reactive Oxygen Species (ROS) 
generation as a byproduct from the interaction between the resveratrol and transition 
metals, especially Zn(II). Therefore, the ROS levels of NHPrE cells treated with 3 
levels of resveratrol (0, 2.5 and 10 µM) and 4 levels of zinc status (ZD, ZN, ZA and 
ZS) were determined using a dye named 5-(and-6)-chloromethyl-2', 7'-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA), a cell-permeant 
indicator for ROS. The increase of resveratrol concentration in culture medium 
significantly enhanced cellular ROS level of NHPrE cells, starting from 2.5 µM and 
reaching the highest at 10 µM, at each zinc level after one day of incubation, as 
indicated by the resveratrol dose dependent increase of fluorescent signal (Fig. 9). In 
ZA and ZS cells, ROS levels appared to be higher than ZD and ZN NHPrE cells 
treated with resveratrol. 
Morphological changes such as flatten shape, larger volume, larger nuclei and 
wide spread of cell body were observed in resveratrol treated NHPrE cells, 
especially in the ZA and ZS cells (Fig. 10). Moreover, these treated cells were not as 
tolerable as the controls to the sub-optimal culturing environment. Exposure of the 




temperature for 15 min resulted in the cells becoming dismembered and could not 
recover as the control cells (data not shown).   
Since the observed morphological changes of NHPrE cells match the 
description of those detected in cells undergoing senescence, senescent NHPrE cells 
in the same experimental design as in the ROS assay were detected by a senescence 
detection kit designed to histochemically detect senescence-associated expression of 
β-galactosidase (SA-β-Gal) activity by x-gal in cultured cells. The percentage of 
senescent cells increased following the resveratrol concentration ladder in all 4 zinc 
treatements. Increased zinc concentration appeared to induce enhanced senescence 
when cells were treated with 2.5 or 10 µM resveratrol (Fig. 11). The strongest effect 
was observed in the ZA and ZS cells, with about 10% and 70% cells undergoing 
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Figure 9. The effect of resveratrol and zinc on reactive oxygen species (ROS) 
generation in NHPrE cells. NHPrE cells were cultured in Nunc Lab-Tek II Chamber 
Slide (8 wells) and treated by 3 levels of resveratrol (0, 2.5 and 10 μM) and 4 levels 
of zinc (ZD, ZN, ZA and ZS) for 24 hours before being stained by 10 µM 5-(and-6)-
chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA), a cell-permeant indicator for ROS for 30 min at 37 oC. After that, cells 
were observed under a fluorescent microscope with excitation wavelength at 470 nm, 
emission wavelength at 525 nm and magnification at 100X.  Pictures on the left 
column show the cells under normal setting (no fluorescence), while pictures on the 
right show the cells under fluorescence settings (with fluorescence). Shown image is 
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Figure 10. Morphological change caused by resveratrol and zinc treatment in 
NHPrE cells. NHPrE cells were cultured in Nunc Lab-Tek II Chamber Slide (8 wells) 




ZA and ZS) for 3 days before being examined under a microscope at a magnification 
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Figure11. The effect of reserveratrol on senescence in NHPrE cells. NHPrE cells 
were cultured in 24-well plates and treated by 3 levels of resveratrol (0, 2.5 and 10 
μM) and 4 levels of zinc (ZD, ZN, ZA and ZS) for 3 days before being fixed and 




over with 70% glycerol and observed under a microscope at a magnification of 100X. 
Black arrows point to the cells that are undergoing senescence (blue color indicating 






There have been a large volume of reports on the anticancer activity, 
antioxidant activity and pro-longevity activity of the health-promoting 
phytochemical, resveratrol. In the US market, resveratrol has been commercially 
available in the form of neutraceutical supplements. However, there are only very 
few studies tackling the undesired aspect of resveratrol such as its prooxidant 
activity. No previous study has ever used a cell-based approach to examine 
resveratrol supplementation in the context of nutrient interaction between 
phytochemicals and trace minerals, specifically, with resveratrol and zinc. Our study 
was designed to address this issue by using resveratrol and zinc as an example to 
build a feasible and efficient model to investigate the interaction between 
phytochemical supplements and trace mineral. NHPrE cells were selected as our cell 
model system because they represent normal prostate tissue and they accumulate 
high levels of zinc. Human hepatoblastoma HepG2 cells was used to represent the 
liver cells, as no normal human liver cells are commercially available. 
Strong cell growth is normal for low passage normal human prostate cells but 
would decline drastically in high passage cells. This was demonstrated by the usage 
of low passage cells in the present study. NHPrE cells in the control group (R0 cells 
treated without resveratrol) from all zinc treatments had doubled more than 3 times 
at the end of 3 days of culture. Cell growth of NHPrE cells was significantly 
affected by the treatment of resveratrol, with more that 80% reduction with 10 μM 
resveratrol after 3 days of culture (Fig. 1A). In another study, which used the same 




proliferation after 3 days of incubation (Hudson et al., 2007). The very low growth 
rate of cell doubling (less than once in the last 2 days of a 3-day-culture) may 
indicate that high passage cells were used and may explain for the lack of inhibition 
of proliferation in resveratrol treated NHPrE cells reported by Hudson et al. (2007).  
In the present study, zinc status only slightly inhibited cell growth of ZD and 
ZS NHPrE cells (Fig. 1A), which partially confirmed the results from Han (2007) in 
our lab that found 39% cell growth reduction in the ZD cells using exactly the same 
cells without resveratrol treatment. Most importantly, a slight 20% enhancement of 
cell growth with low dosage of resveratrol treatment (0.5 µM) was observed in the 
ZN cells (Fig. 1A). These results suggest that low dosage of resveratrol might help 
improve cell proliferation and promote longevity, as reflected by the ‘French 
paradox’ in a bigger picture (Renaud and de, 1993).  
The resveratrol induced dramatic increase of total cellular zinc level in NHPrE 
cells suggests possible intereaction between resveratrol and zinc. Since the liver is a 
very important organ responsible for heavy metal metabolism and storage, we 
wondered if the liver cells have the same response to resveratrol treatment as 
prostate cells do. To our surprise, the HepG2 cells used in our system to represent 
liver were not affected by resveratrol treatment in cell proliferation and total cellular 
zinc content. Zinc deficiency (ZD) exerted a modest inhibition (~20%) on the 
proliferation of HepG2 cells (Fig. 2A), just as reported by previous studies in our lab 
(Wong et al., 2007). In addition, intracellular zinc content in HepG2 cells did not 
vary much between different zinc levels ranging from 1-2.3 nmol/million cells. 




NHPrE cells, we found only 3 fold difference in the control group ZNR0 (4 µM zinc, 
0 µM resveratrol), but more than 10 fold difference in ZNR10 (4 µM zinc, 10 µM 
resveratrol) or ZSR10 (32 µM zinc, 0 µM resveratrol) group. These results again 
confirmed the ability of prostate cells to accumulate 10-fold higher zinc as compared 
to cells from other organs, e.g. liver and kidney (Suzuki et al., 1991; Costello et al., 
2004) and suggested that the cell proliferation inhibition observed in resveratrol 
treated NHPrE cells may be related to the increase of total cellular zinc content. 
Under normal circumstatnce, zinc uptake into the cells and its transport into 
and out of the intracellular organelles are accomplished by its transporters, which 
span the membranes and facilitates the movement of zinc (Eide, 2006). However, in 
our present study, in view of the marked increase of total intracellular zinc with the 
addition of resveratrol starting from 5 μM in ZD, ZN and ZA cells and 1 μM in ZS 
cells,  the zinc uptake may not only rely on the zinc transporters that are located on 
the cell membrane under resveratrol treatment. Other channels may be activated by 
resveratrol treatment and let extra zinc in. Since resveratrol has been shown to be 
able to form resveratrol-Cu(II) complex with Cu(II) resulting in the reduction of Cu 
ions and the formation of reactive oxygen species (Ahmad et al., 2000), the 
similarity between the atomic structure of zinc and copper leads us to the hypothesis 
that resveratrol may chelate zinc to form a complex, which passes the cell membrane 
through a channel specific for resveratrol. 
The direct way to address this hypothesis is to isolate and measure the 
formation of resveratrol-Zn(II) complex inside the cells, which is very difficult. 




establish the existence of the complex by showing the resveratrol dose dependent 
quenching of the fluorescent signal emitted by the complex formed by zinquin and 
Zn(II) (Fig. 4) . These results clearly indicated that resveratrol was able to compete 
for Zn(II) with zinquin, leading to less Zn(II)-zinquin complex formation that emits 
less fluorescence. The only possible explanation for this chelating effect of 
resveratrol for zinc is that resveratrol is able to form complex with Zn(II), just as 
with Cu(II), which was accompanied by the generation of hydroxyl-radical (·OH) as 
established by Electron Paramagnetic Resonance (EPR) (Burkitt and Duncan, 2000). 
This complex forming and prooxidant property of resveratrol with copper was later 
established to be hydroxyl group dependent, since trans-stilbene without the 
hydroxyl groups was found inactive in Cu(II) dependent, resveratrol promoting 
DNA breakage (Azmi et al., 2005).  
Most of the total cellular zinc detected by atomic absorption spectrophometry 
is very tightly bound to MT or other cellular proteins for various functions and 
essentially non exchangeable (Zalewski et al., 1993; Coyle et al., 1994). The other 
pool of intracellular zinc, which is a very small fraction, remains labile and is 
dynamically exchangeable with tightly bound and extracellular zinc pools. The 
intracellular labile zinc pool is metabolically important because it responds to zinc 
deprivation or supplementation by decreasing or increasing its content, respectively 
(Zalewski et al., 1993). As resveratrol is able to increase total intracellular zinc 
dramatically, the intracellular free labile zinc content may be altered by the 
interaction of resveratrol and zinc in our cell system.  Two methods were employed 




methods utilized the same chemical: zinquin ethyl ester, a membrane–permeant 
fluorophore specific for Zn(II), and are based on the same principle: the content of 
labile free zinc is proportional to the fluorescent signal emitted by the complex 
formed by zinquin ethyl ester and Zn(II). Zinquin ethyl ester, instead of zinquin, was 
chosen due to an ethyl ester in place of the 6-mehtoxy group of 
toluenesulphonamidoquinoline in the molecular structure of zinquin ethyl ester, 
which facilitates its retention in living cells and enhances its fluorescent signal. With 
the usage of zinquin ethyl ester, we were able the identify the subcellular 
localization of free labile Zn(II) in extranuclear secretary granule, which is 
consistent with the findings of two previous reports (Smith et al., 2008; Truong-Tran 
et al., 2000). Results from both methods indicated that free labile zinc increases 
along with the extracellular zinc concentration while resveratrol tends to increase 
free labile zinc level in ZA and ZS group but decrease free labile zinc level in ZN 
and ZD group (Fig. 5 and 7). These findings suggest that resveratrol may enhance 
the effect of total intracellular zinc on intracellular free labile zinc content. As a 
matter of fact, the positive correlation of extracellular zinc, total cellular zinc, 
intracellular free zinc as well as MT mRNA (Fig. 1B, 8, 5 and 7) observed in the 
present study was also reported in a rat hepatocytes study using both methods 
(Coyle et al., 1994), which provided supportive evidence to the results of our study. 
Since all of our experimental results favor the contention that resveratrol 
enhances zinc uptake by complex formation, we then asked the question: are these 
extra intracellular Zn(II) bound to MT, converted to free labile zinc or remained 




levels in NHPrE cells treated with zinc and resveratrol using a highly sensitive and 
reproducible method, Quantitative RT-PCR. Total MT mRNA levels were found to 
be elevated by two-fold in ZS cells but unchanged in ZD cells in our system (Fig. 
8A) A 13-fold induction and onefold suppression of MT-1 mRNA by 40 µM of zinc 
supplementation and 10µM TPEN depletion was detected by Q-RTPCR and 
reported by Cousins et al. (Cousins et al., 2003). To facilitate the better 
understanding of our result, we need to indicate that MT-1 is only part of the targets 
of our MT probes and primers which were designed to detect the transcript level of 8 
MT isoforms: MT1H, MT-1H-like, MT-1G, MT-1L, MT-1E, MT-1A, and MT2, 
which are the most abundantly expressed in human mononuclear cells. In fact, 
another study that used the same MT probes reported only 2-fold induction of total 
MT mRNA level by modest oral zinc supplementation (15 mg of Zn as ZnSO4 / day) 
for 10 days in leukocytes from human subjects (Aydemir et al., 2006). Since this 
result was achieved under physiological condition just as in our experimental system, 
it is reasonable to believe that the expression of total MT mRNA is fairly stable and 
does not fluctuate much regardless of zinc status under physiological condition, 
although some isoforms of the MT family do, such as MT-1. We also investigated 
the expression of metal-regulated transcription factor-1 (MTF-1) mRNA, an 
upstream regulator of MT, under the influence of zinc and resveratrol. To our 
surprise, there was little or no change in the mRNA level of MTF-1 among the 
treatments. However, the MTF-1 mRNA abundance in the ZD cells treated with 10 
µM resveratrol was significantly higher than that in the ZN and ZS cells not treated 




3-fold induction of MTF-1 mRNA was reported in 10 µM PTEN induced zinc-
deficient human THP-1 mononuclear cells (Cousins et al., 2003). Comparing the 
fold difference of induction, it is not difficult to note that zinc deficiency induction 
by medium zinc depletion is not as severe as by TPEN chelation. However, more 
importantly, the latter is not clinically practical and feasible.  
On the other hand, the positive results of the senescence assay (Fig. 11) gave 
strong support to the hypothesis that resveratrol enhances zinc uptake by complex 
formation, because the formation of resveratrol-Zn(II) complex is very likely to 
generate reactive oxygen species that could cause DNA damage inside the cells. 
Senescence is one way for the cells to choose to prevent ROS-induced 
carcinogenesis if they do not become apoptotic, which was established by the clean 
apo zone in the histograms of cell cycle analysis (Fig. 3). The increased percentage 
of cells undergoing senescence along with increased zinc and resveratrol 
concentration may be explained by more ROS generation as the result of enhanced 
complex formation, as supported by the strong positive association between the 
percentage of senescent cells and the quantity of ROS generated within the cells 
(Fig. 9). 
In sum, the results of this study suggest the possible existence of interaction 
between Zn(II) and resveratrol. Due to the 3 parallel hydroxy groups in the 
molecular structure of resveratrol, Zn(II) and resveratrol are able to form complex at 
a 1:1 or up to 3:2 ratio in a dynamic equilibrium depending on the availability of 
Zn(II) and resveratrol. In ZD and ZN cells, intracellular zinc concentration is 




the binding capacity of resveratrol for Zn(II) is not saturated yet. However, in ZA 
and ZS cells, the chelating capacity of resveratrol for Zn(II) has been saturated due 
to increased availability of Zn(II). When the complexes formed by Zn(II) and 
resveratrol pass through cell membrane and remain in the coupled form in the 
senescent, metabolically inactive cells, the unsaturated resveratrol under ZD and ZN 
condition keeps chelating the Zn(II) from the free labile zinc pool, which causes a 
decreasing trend of labile free zinc. On the contrary, in ZA and ZS cells with an 
elevated level of total cellular zinc, a small portion of Zn(II) bound to the saturated 
resveratrol starts to dissociate from the complex to join the free labile zinc pool, 
resulting in a modest increase of free labile zinc in the presence of a dramatic 
increase of total cellular zinc (Fig. 12). 
4.6 Conclusion 
In conclusion, resvertrol significantly inhibits the growth of NHPrE cells 
through induction of cell cycle arrest at G2/M stage as well as senescence, but has 
no effect on the proliferation of HepG2 cells. In NHPrE cells, the intracellular total 
zinc enhancement effect of resveratrol was established to be through possible 
complex formation with Zn(II) and was accompanied by ROS generation. However, 
resveratrol treatment exerted little or no effect on the mRNA abundance of total MT 
mRNA and MTF-1 mRNA. Moreover, resveratrol tended to decrease intracellular 
free labile zinc of NHPrE cells cultured in normal (ZN) or low zinc (ZD) 
environment but increase intracellular free labile zinc of NHPrE cells cultured in 
high zinc (ZA) and (ZS) environment. All of the results can be explained by the 
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Figure 12. Proposed dynamic equilibrium theory for the interaction of 
resveratrol and zinc in NHPrE cells. Whithout zinc supplementation (ZD and ZN), 
resveratrol binds Zn(II) tightly due to lower zinc availability, enters the NHPrE cells 
as a complex and remains coupled with Zn(II) intracellularly. On the contrary, with 
zinc supplementation (ZA and ZS), resveartrol’s binding capacity for zinc is 
mitigated by increased zinc availability. As more and more resveratrol-Zn(II) 
complexes enter the NHPrE cells, a small portion of Zn(II) dissociates from the 
complex and joins the intracellular labile free zinc pool. The dissociation of 
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